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Matthew Tyler Hougland 
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 Traumatic spinal cord injury (SCI) results in changes to the anatomical, 
neurochemical, and physiological properties of cells in the central and peripheral nervous 
system.  Neurotrophins, acting by binding to their cognate Trk receptors on target cell 
membranes, contribute to modulation of anatomical, neurochemical, and physiological 
properties of neurons in sensorimotor circuits in both the intact and injured spinal cord. 
Neurotrophin signaling is associated with many post-SCI changes including maladaptive 
plasticity leading to pain and autonomic dysreflexia, but also therapeutic approaches such 
as training-induced locomotor improvement.  Here we characterize expression of mRNA 
for neurotrophins and Trk receptors in lumbar dorsal root ganglia (DRG) and spinal cord 
after two different severities of mid-thoracic injury and at 6 and 12 weeks post-SCI.  
There was complex regulation that differed with tissue, injury severity, and survival time, 
including reversals of regulation between 6 and 12 weeks, and the data suggest that 
natural regulation of neurotrophins in the spinal cord may continue for months after birth. 
 
   iii 
Our assessments determined that a coordination of gene expression emerged at the 12 
week post-SCI time point and bioinformatic analyses address possible mechanisms. 
Additionally, we sought to determine if the regulatory patterns we observed were perhaps 
due to an inflammatory molecule that mediated the coordinated expression pattern that 
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1.1 Spinal cord injury 
 Estimates of the global occurrence of spinal cord injuries (SCI) are in the range of 
100000 to 300000 new cases reported each year (Barbeau H 1999).  Many factors 
contribute to the spontaneous recovery (or lack thereof) observed in patients with SCI as 
a result of changes in the injured spinal cord, with many functional aspects of daily life 
being negatively affected.  In particular, locomotion is among the most common and 
debilitating of these.  Limited independent mobility is associated with lower life 
satisfaction and quality of life post-SCI, and enhancing sensory and locomotor capability 
of patients with SCI has a dramatically positive effect (Putzke JD 2002). 
  Traumatic injury to the spinal cord results in a variety of changes not only to 
neurons within the spinal cord but throughout the entire sensorimotor circuitry.  Sensory 
neurons of the dorsal root ganglia (DRG) rapidly undergo long-lasting changes in their 
electrophysiological properties and growth capacity (Bedi SS 2010; Bedi SS 2012; 
Walters 2012). Locomotor circuitry in the spinal cord caudal to an injury site undergoes 
plasticity at the cellular, synaptic, and connectivity levels in an activity dependent manner 
after injury in humans and experimental models (Edgerton VR 2004; Rossignol S 2006; 
Petruska JC 2007).  One strategy to restore function after spinal cord injury (SCI) is 




 1.2 Locomotor rehabilitation training and activity dependent plasticity 
 Factors that determine the functional outcome after training include both 
the severity and location of the injury. Based on these factors, some patients with 
incomplete SCI can improve walking ability after rehabilitation training (Wernig A 
1995).  A similar degree of improvement has not been shown in motor complete injuries, 
but several weeks of treadmill training can increase the load bearing capacity of clinically 
complete patients (Dietz V 1995).  These changes can partially be attributed to a 
reorganization of sensorimotor circuits. For example, (Grasso R 2004) showed that in 
ASIA A/B patients (complete motor loss) and ASIA C/D patients (incomplete motor loss) 
with body weight supported treadmill training (BWST), levels of activation of motor 
neuron pools show drastic spatiotemporal changes when compared with controls (healthy 
subjects) (Figure 1), though foot placement was roughly equal between all groups. These 
and other studies (Beres-Jones JA 2004, Ivanenko YP 2003, for review see Dietz V 2002) 
highlight the ability of the injured human spinal cord to produce rhythmic patterns that 
are modulated with training. 
 A degree of locomotor capability can also be restored after training in animal 
models.  After transection, cats trained to perform bipedal stepping of the hindlimbs 
improve on the basis of two behavioral criteria.  Trained cats step at speeds six times 
faster and can produce 30-50 more successful steps during an evaluation session than 
non-trained cats. (Figure 2)  During the swing phase, electromyography (EMG) burst 
amplitude increased in the tibialis anterior (TA, an ankle flexor) and decreased in the 
vastus lateralis (VL, a knee extensor) and medial gastrocnemius (MG, an ankle extensor), 
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similar to what is seen in uninjured cats.  This finding is consistent with evidence in 
humans that shows after treadmill training, EMG amplitude in the MG is increased 
during the stance phase, and improper co-activation of the TA during the stance phase is 
decreased (Dietz V 1995). The differences seen in EMG activity were also reflected by 
differences in kinematics; vertical displacement of the ankle was higher in the step-
trained cats, at the end of stance the hindlimbs extended further, and the swing phase 
projected further forward at placement in the trained versus untrained cats (de Leon RD 
1998).  When stand training is provided to transected adult cats for 12 weeks, the load 
bearing capacity of the hindlimbs increased.  At the end of the 12 week training period, 
cats that received stand training were able to maintain full weight-bearing hindlimb 
extension for an average 545 s longer than cats that were untrained.  Longer periods of 
standing are indicative of an enhanced ability to activate hindlimb extensors and thus 
maintain load-bearing extension at the knee and ankle joints.  To test whether the 
characteristics of stepping were retained when the task is no longer practiced, EMG 
amplitude and kinematic assessments were done 6 and 12 weeks after the cessation of 
training.  After 6 weeks, the hindlimb circuitry retained the characteristic patterns that 
were seen at the cessation of training, however by 12 weeks these acquired characteristics 
were lost.  Despite this lack of task specific retention, when the animals were re-trained 
after the 12 week period, they acquired the ability to stand four times faster than with 
initial training (De Leon RD 1999).   
Further evidence for reorganization of the sensorimotor circuitry after injury 
comes from rat models.  In adult rats after contusion injury, treadmill training leads to 
restoration of kinematic stepping parameters seen in the normal state (Heng C 2009).  
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Treadmill training can not only compensate for the decrease elicited by a neonatal 
transection(assessments done in adult rats), but results in larger than normal EPSPs(a 
measure of the synaptic input onto a motoneuron), and reverses the SCI induced increase 
in AHP depth(part of what determines firing frequency of a neuron based on a given 
input current) (Petruska JC 2007).  In the same model, step training enhanced the 
locomotor capability of rats, and this enhancement was not due to regrowth of either 
ascending or descending axons across the site of the lesion (Tillakaratne NJ 2010).   
 In the isolated lumbar spinal cord, reorganization of sensorimotor circuits 
can essentially occur in either the afferent neurons (DRG), interneurons in the spinal 
cord, or the motor neurons themselves (as mentioned above).  Monosynaptic connections 
are made onto interneurons that project both ipsilaterally and contralaterally from group 
Ib and II afferents (Jankowska E 2009), and are important for the pattern generating 
characteristics of sensorimotor circuitry.  These interneurons reside within laminae V-
VIII and can be glutamatergic, glycinergic, or GABA/glycinergic (Bannatyne BA 2009).  
Following injection of the glycinergic inhibitor strychnine, transected adult cats were 
trained to either step or stand for twelve weeks, and stepping ability was then assessed 
after thirty minutes. The cats trained to step showed no difference in stepping ability 
before or after administration of strychnine, however the cats that were trained to stand 
were not initially able to step, but after injection were able to regain full weight-bearing 
stepping.  The group of cats that were trained to step for the first twelve week period, 
were then re-trained to stand for twelve weeks and likewise the cats that were initially 
trained to stand were then re-trained to step for twelve weeks.  Following this additional 
twelve weeks of training, the cats re-trained to stand (that were first trained to step) 
4 
 
showed similar results to the initial twelve week stand trained group in that they were not 
able to step initially but regained the ability after administration of strychnine.  Similarly, 
the cats that were re-trained to step for twelve weeks lost their responsiveness to 
strychnine with results analogous to the step trained group after the first twelve weeks (de 
Leon RD 1999).    Collectively, these studies demonstrate the potential for sensorimotor 
circuits in the lumbosacral spinal cord to develop and retain physiological information in 
an activity dependant manner after training.  
 
1.3  Neurotrophins, Trk receptors and SCI  
The neurotrophins Nerve Growth Factor (NGF), Brain Derived Neurotrophic 
Factor (BDNF), and Neurotrophin 3 (NT3) are secreted growth factors that were first 
characterized for their important role in the survival of subpopulations of sensory neurons 
and in formation of spinal cord sensorimotor circuits during development (Barbacid M 
1995; Lindsay RM 1996; Huang EJ 2001).  In addition to these essential roles in 
establishing the physiological patterns of developing neural circuitry, neurotrophins are 
implicated as having a role in activity dependent changes associated with restoration of 
function after spinal cord injury. 
When uninjured rats are trained for five days and sacrificed at different time 
points after training, BDNF levels increase two hours post training in the spinal cord and 
at all time points in the soleus muscle.  NT3 showes a similar expression pattern to 
BDNF, with elevated levels two and six hours after training in the cord and at all time 
points in soleus muscle (Gomez-Pinilla, 2001).  NT3 and its high affinity receptor TrkC 
were further analyzed at three and seven days after voluntary wheel running.  NT3 
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mRNA and protein levels in the lumbar spinal cord were elevated both three and seven 
days after voluntary exercise.  In the soleus muscle, NT3 mRNA and protein levels were 
elevated at all points.  TrkC mRNA was elevated in the cord significantly at both time 
points, and protein after three days (Ying Z 2003).  These studies suggest a similar 
pattern of regulation for the neurotrophins in the uninjured cord, but also provide a basis 
for how their regulation changes after injury.   
 Using spinal isolation (SI), which eliminates all supraspinal and afferent input to 
lumbar spinal cord, both NT3 and BDNF were down-regulated in the lumbar region 
bereft of input.  In the same study, when botulinum toxin was injected unilaterally into 
the muscle, eliminating efferent output to the ipsilateral muscle but leaving the sensory 
input intact, NT3 expression was increased in the ipsilateral hemicord compared to the 
contralateral hemicord, while BDNF was decreased (Gómez-Pinilla F 2004).  In the 
lumbar cord after hemisection, rats were placed in either a trained group or sedentary 
group and their levels of neurotrophins were analyzed at several time points.  BDNF 
levels of trained rats decreased after injury and were restored after training, while NT3 
stayed the same as controls after injury and with training expression levels were 
significantly elevated after 28 days (Ying Z 2005).   
Rats with a moderate mid-thoracic contusion subjected to three different types of 
exercise (treadmill, stand, and swim) show altered expression levels of the neurotrophins 
BDNF and NT3 in both the spinal cord and soleus muscle (ankle extensor).  As seen with 
hemisection, BDNF expression in the cord decreased after injury, but all forms of 
exercise restored expression to levels seen in controls.  In the soleus muscle, only the 
group with treadmill training returned to pre-injury levels.  Levels of NT3 expression 
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were elevated in both the cord and soleus muscle with all the exercise regimes (Figure 3) 
(Hutchinson KJ 2004).  Delivery of exogenous BDNF and NT3 to the transected spinal 
cord improves recovery of hindlimb function (Blits B 2003)(in rats) and results in a level 
of function similar to that seen in animals receiving locomotor training after spinal 
transection (Figure 4) (Boyce VS 2007)(in cats). In light of the demonstrated and 
suggested roles in modulating sensorimotor physiology, characterizing the endogenous 
regulation of neurotrophins and their receptors after injury is particularly relevant. 
 
1.4  Neurotrophins and Physiology 
 Neurotrophins have key roles in modulating the anatomical, 
neurochemical, and physiological properties of cells in the central and peripheral nervous 
system.  The effects of neurotrophins on responses to stimuli in both the intact and 
injured nervous system have been extensively investigated and studies have demonstrated 
an important role in modulation of sensorimotor physiology (Huang EJ 2001; Huang EJ 
2003; Reichardt LF 2006; Skaper SD 2008; Skaper SD 2012). The neurotrophins have 
therefore become a frequent target for manipulation after injury.  
Physiological and behavioral studies have established NGF as a nociceptive 
agonist. NGF administration to neonatal, juvenile, and adult rats over the course of 9 
weeks results in a decrease in both mechanical and thermal withdraw latency, indicated 
hypersensitivity to both types of stimuli (Lewin GR et al. 1993). These findings are also 
extended to the single cell level, evident by the finding that nociceptive DRG neurons 
responsive to capsaicin are sensitized upon application of NGF (Shu and Mendell 2001).  
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After subcutaneous injection of BDNF and NT3 into neonatal rats, an 
enhancement in the response of motoneurons to increasing intensities of dorsal root 
stimulation after BDNF was seen in the polysynaptic component, whereas no change is 
observed in the monosynaptic component.  In contrast, after NT3 injection, the 
monosynaptic component showed the greatest increase, with an increase in the 
polysynaptic component also observed to a lesser degree.  Additionally, four treatments 
were administered; BDNF, TrkB-IgG (blocks BDNF signaling), NT3, and TrkC-IgG 
(blocks NT3 signaling).  TrkB-IgG and NT3 both increased the average amplitude of the 
EPSP, while TrkC-IgG and BDNF had the opposite effect (Figure 5) (Seebach BS 1999). 
These results indicate that the levels of these neurotrophins have potentially different 
effects following postnatal injection, in that NT3 potentiates the monosynaptic 
component of the EPSP and to a lesser degree the polysynaptic component, while BDNF 
enhances the exclusively the polysynaptic component.  
 These results are also consistent with the notion that TrkB activation has an effect 
on plasticity through facilitation of GABAergic transmission (i.e. interneuron) (Pezet S 
2002),  TrkB ligands have a suppressive effect on mechanosensory plasticity in the 
deafferented spinal cord (Ramer LM 2007), and have been shown to hypersensitize 
neurons of the superficial dorsal horn receiving high threshold primary afferent input 
(Garraway SM 2003), highlighting the broad physiological  role of TrkB ligands in the 
function of the nervous system.  
When the distal stump of the MG nerve in axotomized cats is placed in NT3, they 
exhibit Ia EPSPs 2.5 times normal, and 5 times larger than the axotomized that are left 
untreated.  Conduction velocity of group I afferents in treated animals recovered to 
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normal values (Munson JB 1997).  Removal of NT3 four to five weeks later results in a 
subsequent decline in both EPSP and conduction velocity within one week to values 
observed in the axotomized group, while NT4/5 (a TrkB ligand) causes a limited 
improvement in conduction velocity with no effect seen in the EPSP (Mendell LM 1999). 
This is also the case for chronic application of NT3, as fibroblast implants into the 
lumbosacral cord enhanced the EPSP from both central and segmental inputs (Arvanian 
VL 2003).  Additionally, cultered dorsal root ganglion cells allowed to grow in BDNF 
and NT3 conditioned media from AAV infected HEK cells exhibit robust neurite 
outgrowth (Blits B 2003).Taken together, these studies suggest that neurotrophins can 
support both anatomical and physiological forms of plasticity 
 
1.5  Neurotrophins/Trks expression in sensorimotor circuits after injury 
Neurotrophins influence cellular processes by binding to membrane-bound 
receptors which transduce the extracellular signal into intracellular effect – their high 
affinity tyrosine kinase receptors. In general, NGF binds TrkA, BDNF binds TrkB, and 
NT3 binds TrkC (Barbacid M 1995; Patapoutian A 2001; Huang EJ 2003), although 
cross-talk is recognized and there is a low-affinity pan-neurotrophin receptor p75, which 
we do not consider here. To determine the role of neurotrophins in any process or 
condition one must examine not only the neurotrophins, but also the receptors. 
Prior characterizations of changes in neurotrophins and Trk receptors in lumbar 
neural circuitry have been instrumental in elucidating the complex regulation of these 
important molecules after injury (Table 1). However, these have largely focused on time 
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points of less than 6 weeks (Hayashi M 2000; Liebl, Huang et al. 2001; Liebl DJ 2001; 
Nakamura M 2001; Widenfalk J 2001; Qiao and Vizzard 2002; Qiao L 2002; Gulino R 
2004; Zvarova, Murray et al. 2004; Qiao and Vizzard 2005; Qiao LY 2005; Qian DX 
2006; Li XL 2007; Hajebrahimi, Mowla et al. 2008; Hajebrahimi Z 2008; Qian, Zhang et 
al. 2011; Qian DX 2011; Keeler BE 2012). Although valuable for elucidating the role of 
neurotrophin signaling in the first 6 weeks after SCI, these data are of uncertain value for 
relating to longer-term post-SCI function. Given the many demonstrations of continued 
changing conditions after SCI (Beattie, Hermann et al. 2002; Profyris, Cheema et al. 
2004; Ung, Lapointe et al. 2008; Beck, Nguyen et al. 2010), it is important to recognize 
that the temporal character of experiments has a significant influence on the outcome. 
 
1.6 Inflammation and SCI  
 Another important aspect of SCI that affects cellular processes and influences 
how the nervous system responds to injury is inflammation. In humans after SCI, 
neutrophils, macrophages, and lymphocytes enter the cord through hemorrhage or 
extravasation, inducing a robust microglial response (Fleming, Norenberg et al. 2006). 
This cellular infiltration acutely after traumatic injury results in an upregulation of 
inflammatory factors in endogenous cells of the nervous system (neurons and microglia) 
such as IL1beta, IL6, and TNFalpha (Yang, Blumbergs et al. 2004). In rats, early 
transient increases in IL1beta, IL6 and TNFalpha are injury severity dependent, and as is 
the case in humans, is a result of upregulation of expression in neurons and microglia, not 
blood borne leukocytes (Yang, Jones et al. 2005). The acute early release of these 
cytokines leads to induction of their mRNA, as mice lacking the receptors for TNFalpha 
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and IL1 exhibit a diminished level of expression of these molecules (Pan, Ni et al. 2002). 
However, this expression pattern is transient, and returns quickly to levels seen in 
controls (Streit, Semple-Rowland et al. 1998).  
 In addition to these cytokines, many others have been identified as being 
upregulated after SCI in rodents such as IL-6, IL-1α, IL-1β, IL-13, CCL2, MIP1α, 
RANTES, and TNFα (Stammers, Liu et al. 2012). This finding can be extended to 
humans in the case of IL-6, IL-8, and CCL2, and has even been suggested as being a 
relevant biomarker for injury severity and subsequent recovery, as they were able to 
better predict the outcome of motor recovery 6 months after injury than the ASIA score 
(Kwon, Stammers et al. 2010). CCL2 has been shown to be upregulated in many models 
of peripheral nerve injury, and has a role in the development of pain after peripheral 
nerve injury (Tanaka, Minami et al. 2004; Jeon, Lee et al. 2008; Bhangoo, Ripsch et al. 
2009; Jeon, Lee et al. 2009; Foster, Jung et al. 2011).  Similar to IL1beta, induction of 
CCL2 expression can be accomplished through the actions of TNFalpha (Jeon, Sung et 
al. 2011). TNFalpha has also been shown to lead to hyperalgesia in models of peripheral 
inflammation, through regulation of both NGF (Woolf, Allchorne et al. 1997) and 
BDNF-TrkB (Lin, Ro et al. 2011). Thus, in studies investigating SCI and neurotrophin 
regulation, examination of cytokines and other markers of inflammation could prove to 
be instrumental in uncovering novel interactions that govern expression of plasticity 















MATERIALS AND METHODS 
 
 
2. Materials and methods  
 
All experimental protocols and procedures were approved by the Institutional Animal 
Care and Use Committee at the University of Louisville, Louisville, KY.  Experimental 
animals were 7 week old female Sprague–Dawley rats (Taconic Labs, Hudson, New 
York).  Animals were housed in pairs throughout the course of our experiments. 
 
2.1 Surgical spinal cord injury  
Rats (n = 47) were anesthetized with 50mg/kg sodium pentobarbital (Sigma, St Louis, 
MO).  Once sedated, Lacquer Lube was applied to the eyes to prevent drying.  After skin 
incision, laminectomy was performed at vertebral level T9, to expose the T10 spinal cord. 
Contusion injuries were produced using the New York University (NYU) Impactor. 
Either “Moderate” or “Moderately severe” injuries were produced by releasing a 10g, 
2mm rod from 12.5 mm or 25 mm height, respectively, onto the exposed dura mater of 
the spinal cord. These will subsequently be referred to as 12.5gcm and 25 gcm injuries. 
Immediately after producing the contusion the wound was closed in layers and the skin 
incisions were stapled. Rats received fluids (10cc 0.9% saline subcutaneously), and 
antibiotic treatment (0.1cc Gentamicin (50mg/mL) intramuscularly, and Bacitracin was 
topically applied on the incision site).  Animals were housed overnight in a recovery 
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room with a heating pad under their cage, and were taken to the animal facilities in the 
morning. 
 
Assessment of mRNA expression in SCI animals was compared to control animals. 
These consisted of naïve rats (2 per time point group) and rats receiving laminectomy 
only (3 rats per time point group), for a total of 5 controls per time point.  There were 4 
additional laminectomy-only control rats included with the animals used for the 6 week 
post-SCI DRG assessment. All surgical procedures (except for the spinal cord injury), 
were as described above for the laminectomy-only control rats.  
 
2.2 Injury Characterization 
2.2.1. Behavior 
Experiments were performed on rats separated into groups based on injury severity, 
survival time, and the tissue to be analyzed for mRNA expression.  Rats were 
familiarized with the testing procedures and personnel by handling for 1 week before 
injury. Pre-surgical behavioral assessments were done to ensure no pre-existing 
conditions were present that would subsequently affect our locomotor outcome measures. 
Seventeen rats received 12.5g-cm NYU (moderate) and sixteen rats received 25 g-cm 
NYU (moderately severe) injuries. Hindlimb locomotor function was assessed with the 
Basso, Beattie, and Bresnahan Locomotor Rating Scale (BBB) (Basso DM 1996). BBB 
testing was carried out prior to injury and 7, 14, 21, 28, 35, 42 for the six week spinal 
cord group, and 7, 14, 21, 28, 35, 42, 49, 56, 63, 72, 79, and 84 days post injury for the 
twelve week spinal cord (SC) groups, twelve week dorsal root ganglia (DRG) group, and 
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at 7, 14, 28, and 42 days post injury for the six week DRG group. For testing, rats were 
placed in an open field (a plastic tank that was 105 cm in diameter with 30 cm high walls) 
for 4 min.  BBB testing was done after animal care in the morning.  Hindlimb movement 
and locomotion were scored simultaneously by two observers who were blind to the 
treatment groups. We include the BBB measures as a means to characterize the injuries 
with commonly used assessments so that the mRNA measures can be placed in context. 
 
2.2.2. Histology 
At the end of the testing period, rats were anesthetized with sodium pentobarbital and 
euthanized via transcardial perfusion with 30% RNA Later (Qiagen) in 0.1M Phosphate 
Buffered Saline (PBS). An approximately 10 mm long block of spinal cord containing the 
injury epicenter was removed from each animal and immersed in 4% paraformaldehyde.  
After 1 week cords were immersed in PBS containing 30% sucrose for cryoprotection 
until further processing. For sectioning, tissue was embedded in TissueTek® (VWR) and 
frozen. The blocks were cut 50um thick in the transverse plane on a cryostat and were 
sampled every 250μm.  A series of sections spanning the rostrocaudal extent of the lesion 
was stained with eriochrome cyanine (EC) to assess amounts of spared myelin as 
described (Rabchevsky AG 2007) .  Light microscopy was used to determine spared 
white matter.  Images were captured using a SPOT digital camera (Diagnostic 
Instruments) mounted on a Zeiss Axioskop.  From these, the area of spared tissue was 
manually designated (Intuos drawing tablet; Wacom (Otone, Japan)).  Areas of white 
matter sparing were calculated using the ImageJ program and expressed as a proportion 
of control (defined as group-mean of the smallest white matter area from an analogous 
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section of spinal cord from all control animals). For each injured animal, the spinal cord 
injury epicenter was defined quantitatively as the section containing the least amount of 
intact tissue.  Percent white matter sparing is reported as mean (± standard deviation). As 
with the BBB, we include the WMS measures as a means to characterize the injuries with 
commonly used assessments so that the mRNA measures can be placed in context. 
 
2.3. mRNA expression 
 
2.3.1. Isolation and cDNA conversion 
 
Animals were euthanized after final behavioral assessments and exsanguinated by 
transcardial perfusion using 30% RNA later (Qiagen) in Phosphate Buffered Saline 
(PBS).  Lumbar spinal cords (L4/5) and Dorsal Root Ganglia (DRG) were removed and 
immersed in 100% RNA later and stored at -20°C until further processing.  Spinal cords 
were homogenized on ice in 1mL Trizol and RNA was isolated using Trizol/chloroform 
extraction method.  Briefly, homogenate was transferred to a 1.5mL tube and spun at 
12000g for 10 min at 2°C. The supernatant was transferred to a new tube and 200uL 
chloroform added.  This mixture was spun for 15 min at 2°C to separate into aqueous and 
organic phases.  The aqueous phase was transferred to a new tube and alcohol 
precipitation was performed with 100% isopropanol, then 70% ethanol.  After removal 
and drying of excess ethanol, the pellet was resuspended in 30uL nuclease free H20, 
solubilized in 600uL Buffer RLT with beta-Mercaptoethanol (BME) and processed 
through RNeasy MiniKit (Qiagen) per manufacturers protocol.  DRGs were homogenized 
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directly in Buffer RLT + BME and processed through RNeasy MiniKit.  RNA was 
analyzed by Nanodrop (ThermoScientific, Waltham, MA, USA) to obtain concentration 
and 500ng of RNA from each sample was reverse transcribed into cDNA using Quanta 
Biosciences qScript cDNA SuperMix.  All RNA was converted to cDNA using the same 
lot of reverse transcriptase. Performing the reverse-transcription for all samples with the 
same reagents is a methodological procedure meant to reduce the cross-sample variability 




mRNA expression levels were quantified by qRT-PCR on Corbett Research 6000 
(Qiagen) using FastStart Universal SYBR Green Master Mix(Roche). Duplicate reactions 
were run for each sample for both the gene of interest and the normalizer (Beta-3 Tubulin 
– demonstrated as a suitable normalizer gene for SCI work (Strube C 2008). Relative 
expression levels were calculated as ∆∆CT of gene of interest vs. normalizer.  Primer 
sequences for the genes analyzed are provided in Table 2, along with their relationship to 




Statistical analyses were performed using SPSS (IBM, North Castle, NY, USA) or 
SigmaPlot/SigmaStat (Systat Software, San Jose, CA, USA).  A Student’s t-test was 
performed to determine if expression levels differed between control groups.  In cases 
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where gene expression did not differ between control groups the six and twelve week 
control groups were combined and the expression values for the experimental groups are 
reported as a fold change of the unified control group. One-way analysis of variance 
(ANOVA) was performed on these values with post-hoc Tukey’s test for all pairwise 
comparisons.  All groups with p<0.05 difference are reported as significant.  Pearson 
Product Moment was calculated to determine the relationships between the expression 
levels of the different transcripts, and to determine the relationships between BBB/WMS 
vs. expression levels. Differences between BBB scores were assessed using a mixed 






































EXPRESSION OF NEUROTROPHINS AND TRK RECEPTORS IN 





The impact of SCI varies depending on the location of the injury itself and the 
spatial relation of the investigated tissue to the SCI. The relative composition of types of 
tissues innervated changes throughout the course of the neuraxis as does the specific 
function of local circuitry. For example, in rat, the spinal components of bladder control 
are focussed on the T13/L1 and L6/S1 segments, colon function is focused in L6/S1, and 
the locomotor central pattern generator appears focussed in (though not limited to) the 
L1/2 segments, spinal sympathetic circuitry regulating outflow exists roughly from T1-
L2, and spinal parasympathetic circuitry exists in the sacral-caudal spinal cord. Thus it 
follows that the effect on spared function and/or recovery is influenced by the level of the 
injury (Magnuson, Trinder et al. 1999; Magnuson, Lovett et al. 2005; Garcia-Alias, 
Valero-Cabre et al. 2006), but this also extends to less direct functions (Campagnolo, 
Bartlett et al. 2000; Lucin, Sanders et al. 2007). It is also very important to consider that 
both neural and non-neural tissues remote from the SCI can be affected (Collazos-Castro, 
Soto et al. 2005; Massey, Hubscher et al. 2006; Gris, Hamilton et al. 2008). 
Sensory input to the spinal cord plays a role in establishing recovery and 
regulating spinal function after alteration of descending inputs. For example, urinary 
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bladder function after SCI is highly reliant on afferent input and plasticity of sensory 
components (Tai, Roppolo et al. 2006; de Groat and Yoshimura 2009), and SCI affects 
the trk receptor profile of neurons in DRG segments innervating bladder differently than 
for DRG innervating hindlimb (Qiao and Vizzard 2002; Qiao and Vizzard 2005), a 
finding that extends to spinal trk receptors as well (Zvarova, Murray et al. 2004). 
Additionally, the type and amount of sensory input can influence spontaneous recovery 
after SCI (Grau, Washburn et al. 2004; Ollivier-Lanvin, Keeler et al. 2010; Caudle, 
Brown et al. 2011; Ferguson, Huie et al. 2012; Ferguson, Huie et al. 2012; Grau, Huie et 
al. 2012) and also influence the effectiveness of physical therapy (Bouyer and Rossignol 
1998; Bouyer and Rossignol 2003; Edgerton VR 2004; Gomez-Pinilla, Ying et al. 2004; 
Edgerton, Courtine et al. 2008; Frigon and Rossignol 2009; Ollivier-Lanvin, Keeler et al. 
2010), all of which may involve neurotrophin signaling (Gomez-Pinilla, Ying et al. 2004; 
Hutchinson, Gomez-Pinilla et al. 2004; Boyce, Tumolo et al. 2007; de Leon 2007; Côté 
MP 2011; Boyce, Park et al. 2012). Further, autonomic dysreflexia (AD), a maladaptive 
condition frequently observed in patients with cervical or high thoracic SCI, is often 
triggered by nociceptive sensory input (Maiorov, Fehlings et al. 1998; Krassioukov and 
Fehlings 1999; Garstang and Miller-Smith 2007), and sprouting of central terminals of 
nociceptive neurons, thought to be NGF-dependent, is a proposed mechanism that 
contributes to AD (Weaver, Cassam et al. 1997; Krenz, Meakin et al. 1999; Marsh, Wong 
et al. 2002; Cameron, Smith et al. 2006; Ackery, Norenberg et al. 2007).  
Hence, it is important to examine not only the spinal cord, but also the sensory 
neurons that provide signals to the spinal cord, and to consider that the effects of SCI on 
the afferent neurons may differ in relation to the SCI, and/or to the tissues they innervate 
19 
 
(Qiao and Vizzard 2002; Zvarova, Murray et al. 2004; Bedi, Yang et al. 2010; Bedi, Lago 
et al. 2012; Keeler BE 2012). With these considerations in mind, it is important to 
consider that the spatial parameters of experiments, with regard to both the level of SCI 
and how the SCI affects the tissue investigated, can significantly influence the outcome.  
Injury severity, or more specifically the location and degree of damage to the SC, is 
another key factor that determines the functional capabilities of the spinal cord caudal to 
a SCI. The literature is replete with examples of this when reports are considered 
together, (Rossignol and Frigon 2011), however far fewer single studies examine 
multiple injury severities (Magnuson, Lovett et al. 2005; Smith, Burke et al. 2006), 
despite the fact that the degree of injury severity also significantly influences the 
outcome. 
Thus, we intially sought to characterize natural regulation of neurotrophin and trk 
receptor genes in tissues and conditions that were most applicable to experimental studies 
of long-term function and recovery after SCI and to conditions most often represented in 
animal models and human studies. We characterized the transcriptional response of 
neurotrophins and their cognate Trk receptors to spinal cord contusion temporally (6 and 
12 weeks post-injury), spatially (in lumbar spinal cord and DRG), and relative to injury 




3.2 Results  
 
3.2.1. Injury Characterization 
 
 To assess the degree of injury severity, we characterized spinal cord injuries 
based on two parameters; behavior as measured by BBB, and the amount of spared white 
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matter at the epicenter after staining with eriochrome cyanin (Rabchevsky AG 2007).  
BBB scores were significantly greater in the 12.5 g-cm injury groups than the 25 g-cm 
groups beginning at week 5 (Fig 6a). These differences in behavior were reflected in the 
amount of spared white matter, as the 25 g-cm groups had 8.5% (± 1.8%) and the 12.5 g-
cm groups had 13.9% ( ±3.6%) spared white matter at the epicenter.  In accord with prior 
literature (Basso DM 1996; Schucht P 2002; Magnuson DS 2005), a significant 
correlation (r=0.88, p<0.001) was observed between white matter sparing at epicenter 
and BBB scores (Fig 6b).  BBB scores of the 12.5 g-cm group showed a high degree of 
variability and continued to increase between 6 and 12 weeks instead of reaching a 
plateau.  Within this group, 2 animals had BBB scores consistent with the range observed 
in previous literature (Basso DM 1996; Agrawal G 2010) (12 and 13) and 4 animals that 
had higher BBB scores than expected for this injury severity (mean 17.9) at 12 weeks 
post injury. We considered that these results may be due to both greater amount of spared 
white matter (SWM) and/or asymmetry of the lesion (Fig 6c, 6d).  Indeed, of the 4 
animals whose BBB scores continued to increase, all had a greater amount of spared 
white matter (mean 16.1% for 4 animals with higher BBB scores, 10.1% for 2 animals 
with lower BBB scores), and all had asymmetrical injuries (arbitrarily defined as more 
than 4% greater SWM on one side versus the other). Animals with the lower BBB scores 
in the 12.5 g-cm group did not represent statistical outliers (Grubbs outlier test). Separate 
statistical analyses of gene expression were performed with the exclusion of the 2 
animals whose BBB scores did not continue to increase and the results generally did not 
differ from those found when all 6 animals were considered together. The lone exception 
was the results for expression of one Trk receptor in the spinal cord, which is noted 
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below.  We thus consider all 6 animals together in the group in all subsequent figures and 




3.2.2. Expression of Trk receptors in the DRG  
 One purpose of this study was to determine whether these different contusion 
severities result in a differential transcriptional response of neurotrophins and their Trk 
receptors in lumbar sensorimotor circuits.  Hence, we sought to determine the expression 
level of Trk receptors in the DRG 6 and 12 weeks after our two severities of contusion 
injury. Expression of TrkA, TrkB, and TrkC each differed significantly between the 6 and 
12 week groups, with the magnitude and direction of difference depending on receptor 
type and injury severity. Expression of TrkA mRNA in DRG from the 12 week group at 
both injury severities was significantly greater than that in DRG from the corresponding 
6 week group. Expression of TrkA in DRG from the 12 week group that received 12.5g-
cm injury was also elevated relative to the control groups.  We also observed a difference 
in TrkA expression between injury severities at the 12 week time point. Similar to TrkA, 
expression of TrkC mRNA in DRG from the 12 week group was greater than that in 
DRG from the corresponding 6 week group at both injury severities, but the difference 
only reached significance in the 12.5 g-cm animals.  Unlike the findings for TrkA, we 
detected no significant difference in TrkC expression between DRG from the 12.5 g-cm 
group and from the 25 g-cm group at the 12 week time point.  Expression of mRNA for 
TrkB in DRG at 12 weeks after 25 g-cm injury was significantly lower than in DRG from 
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both the 6 week SCI and control groups.  No significant difference in TrkB expression 
was observed between injury severities at 6 or 12 week time points in the 12.5 g-cm 





3.2.3. Expression of Neurotrophins in the DRG 
 As with TrkA, NGF mRNA expression in DRG from the 12.5g-cm injury severity 
group was significantly greater in the 12-week group than in both the 6 week and control 
groups.  However, no significant changes in NGF expression were observed between 
survival-time groups in the 25 g-cm injury severity group.  As with TrkB, BDNF 
expression in the 12 week 25 g-cm group was significantly less than in the 6 week 25 g-
cm group, but did not differ from the control group (Fig. 8). No other differences were 
observed in BDNF expression levels.  There was a large increase in the mean expression 
of NT3 in DRG from the 12 week, 12.5 g-cm injury group, however due to high variance 
no significant differences were observed from 6 to 12 weeks. 
 
 
3.2.4. Expression of Trk receptors in the spinal cord 
 Expression levels of mRNA for neurotrophin receptors TrkA, TrkB, and TrkC 
were assessed from samples of lumbar spinal cord (L4/5).  In the groups that received a 
12.5 g-cm injury, the level of TrkA in spinal cord from the 12 week group was 
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significantly greater than that from the 6 week group, whereas there was no significant 
difference between the two post-SCI times in the 25g-cm injury group. Like TrkA, the 
level of TrkC in spinal cord from the 12 week 12.5g-cm group was significantly greater 
than that from the 6 week group, with no significant difference between the two post-SCI 
times in the 25g-cm injury group.  No significant changes in TrkB expression levels were 




3.2.5. Expression of neurotrophins in the spinal cord 
 The results for neurotrophins in the spinal cord are displayed differently from the 
data regarding expression levels of neurotrophins and Trk receptors in the DRG, and Trk 
receptors in the spinal cord. In the aforementioned assessments, the expression of 
neurotrophins and trks did not differ between the 6 week and 12 week control animals. 
Thus, those data were analyzed and presented relative to the mean and variation of a 
single unified control group. This allowed us to simultaneously assess the effect of both 
injury severity and survival time on gene expression. For the neurotrophin genes in spinal 
cord, however, expression differed significantly between the 6 week and 12 week control 
groups (Figure 5A). We first analyzed these expression data exactly as was done for the 
other tissues – comparing each injury severity and survival time to the mean and variation 
of a single unified control group – but for the sake of clarity we have presented the data 
from the individual animals in each group. Caution must be taken when considering the 
expression data for the experimental groups in this analysis (Figure 10A) because of the 
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use of a unified control group – i.e., these data were generated exactly as were the other 
expression values, but are relative to a unified control group that, in this case, is not a 
suitable control group. We found decreases between our 6 and 12 week control groups in 
expression levels of NGF, BDNF, and NT3 in the spinal cord in the absence of spinal 
cord injury. It is worth noting that our quality control measures were repeated for these 
samples, but the assessments remained the same.  In ruling out technical issues and 
variability due to the necessity of using animals from different litters, a single factor 
appears to account for the altered expression levels in the control groups, that being age. 
Because the gene expression differed between the 6 week and 12 week control 
groups, we cannot incorporate the temporal characteristic of the experimental design in 
our assessment of neurotrophin expression in spinal cord. We are limited to analyzing the 
effect of injury severity on gene expression within each separate survival time group, 
where the data from experimental groups is expressed relative to the time-matched 
control group only (Figure 10B). Considered in this way, spinal cord injury itself did not 
significantly influence expression of any neurotrophin at any time considered, with the 
exception of NT3 at 12 weeks post-SCI. At this time, NT3 was elevated relative to the 
time-matched control group, with no effect of injury severity. 
 
 
3.2.6. Relationship of transcriptional assessments to functional and anatomical 
assessments  
 Our experimental design was intended to embrace the variability that exists with 
models of contusive SCI in that we also examined whether a statistical correlation existed 
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between expression levels of each transcript and BBB or white matter sparing on an 
animal by animal basis.  We observed no statistically significant correlation between the 




Spinal cord injury leads to many changes that affect both the central and 
peripheral nervous system, indeed the entire organism, with residual functional capacity 
largely dependent on the location and severity of the injury.  Many approaches have been 
used in efforts to re-establish function, including (but not limited to) enhancement of 
regeneration across the injury site (Bregman BS 2002; Moon L 2005; Sharma H 2012; 
Smith GM 2012) and plasticity of intact circuits below the level of the lesion (Edgerton 
VR 2004; Boulenguez P 2009; Rossignol S 2011).  One means for achieving plasticity of 
intact circuits is through activity-dependent reorganization of inputs (Edgerton VR 
2004)).  This phenomenon has been described in both animal (Edgerton VR 2008) and 
human (Harkema SJ 2008) studies of spinal cord injury.  Neurotrophins have been 
associated as playing a key role in induction of such changes (Hutchinson KJ 2004; 
Boyce VS 2007; Côté MP 2011; Boyce VS 2012). However, activity-dependent changes 
in locomotion often manifest at times later than those examined in studies of post-SCI 
expression of neurotrophins and trk receptors (De Leon RD 1998; De Leon RD 1999); 
(Table 3). Indeed, the dynamic period of spontaneous locomotor recovery generally lasts 
for approximately 6 weeks after SCI, a time well beyond the majority of previous studies 
(Table 3). In addition to a putative role in locomotor function, neurotrophin signaling has 
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also been implicated in pathologic outcomes of plasticity such as post-SCI pain and 
autonomic dysreflexia (Brown and Weaver 2012). The role of neurotrophin signaling has 
primarily been examined in terms of initiation of these conditions acutely after SCI in 
animal models (Krenz, Meakin et al. 1999; Marsh, Wong et al. 2002; Cameron, Smith et 
al. 2006), as opposed to later-phase initiation or maintenance. The regulation we have 
demonstrated at extended time points may provide new rationale for examining the role 
of neurotrophin signaling in later stages of these conditions. 
Neurotrophins exert modulatory effects on cellular physiology through activation 
of their cognate Trk receptors (Lindsay RM 1996; Patapoutian A 2001; Huang EJ 2003).  
In the DRG, expression of neurotrophin receptors is restricted to specific populations of 
cells.  Generally, TrkA is expressed in neurons with small soma size, TrkB in neurons 
with intermediate size, and TrkC in neurons with large soma size; populations of TrkA 
and TrkC expressing neurons remain largely separate, whereas TrkB is co-expressed in 
overlapping populations of TrkA and TrkC positive cells (Mu X 1993; McMahon SB 
1994; Wright DE 1995; McMahon SB 1996; Phillips HS 1996). Trk receptors are not 
ubiquitous, however, as there is a large subpopulation of small diameter DRG neurons 
which do not express any of the Trk receptors or the low-affinity neurotrophin receptor 
p75 in the adult (McMahon SB 1994; Molliver DC 1997; Bennett DL 1998).  In the 
mammalian spinal cord, TrkA is expressed in second order nociceptors of the dorsal 
horn, TrkB has a broad pattern of expression which overlaps with both TrkA and TrkC 
expression, and TrkC is expressed in neurons of the intermediate and ventral horn 
(Duberley RM 1997; Curtis R 1998; Schober A 1999; Copray S 2000; Liebl DJ 2001); 
also available from: http://mousespinal.brain-map.org. 
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As long as 6 weeks after spinal cord transection injury, the number of cells 
expressing TrkA and TrkB protein in L1 and L6/S1 DRG (containing bladder afferents) 
increases over controls, though the numbers of cells expressing these genes does not 
significantly change in L4/5 DRG (Qiao L 2002; Qiao LY 2005).  Our analysis of Trk 
expression, which was also performed in L4/5 DRG, found no significant change in the 
trkA or trkB mRNA levels for either severity of contusion injury at 6 weeks post injury, 
in agreement with the prior work.  In intact sensory and sympathetic ganglia of the adult 
rat, NGF and NT3 (as well as TrkA, full length TrkB, and TrkC), localize exclusively to 
neurons; BDNF and the truncated isoform of TrkB are expressed more extensively, 
however, localizing to neuronal cells and some glial and satellite cells (Wetmore C 
1995). These observations are consistent with the notion that full length Trk expression 
predominantly occurs in neurons, though since the latter study was performed with intact 
animals, we cannot exclude the possibility that our injuries potentially resulted in ectopic 
expression in other cell types. Indeed, there are numerous reports of trk receptor 
expression by non-neuronal cells. In particular Schwann cells can express trks, as can 
cancer cells (Funakoshi, Frisen et al. 1993; Tacconelli, Farina et al. 2005; Hess, Scott et 
al. 2007; Jin, Lee et al. 2011). Further, neurotrophins are often expressed in non-neuronal 
cells, most notably by cells outside the nervous system where they influence both 
developmental and adult processes (Lewin 1996; Petruska and Mendell 2004). 
Previous assessments of changes in neurotrophin/Trk receptor expression levels 
after spinal cord injury have typically focused at time points of less than 6 weeks.  BDNF 
expression increases up to two weeks after injury in the spinal cord after thoracic 
transection and crush injury (Hayashi M 2000; Li XL 2007), though both increases and 
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decreases in expression have been reported after hemisection during a similar time period 
post injury (Gulino R 2004; Qian DX 2006).  Expression levels of NGF and NT3 in the 
cord increase for up to 3 weeks after spinal cord injury (Hayashi M 2000; Li XL 2007).  
In another study, NGF and BDNF transcripts were found to increase up to 4 days 
following injury in the adult cord, however, by 2 weeks post injury all neurotrophins 
were expressed at levels similar to that of control (Nakamura M 2001; Widenfalk J 
2001), suggesting expression decreases after an early increase, though these studies used 
different injury models.  Trk mRNA expression is downregulated acutely in the spinal 
cord at and around the injury site after contusion (Liebl DJ 2001; Hajebrahimi Z 2008), 
however by 6 weeks expression levels are not different from control (Liebl DJ 2001).  
However, after spinal cord transection TrkC has been shown to increase after two weeks 
(Qian DX 2011).  Similarly, in a recent study assessing mRNA and protein changes after 
transection at 10 and 31 days post injury, whole spinal cord TrkB mRNA was elevated at 
10 days post injury, and whole spinal cord NT3 and TrkB protein was elevated at 31 days 
post injury, with expression differences also observed depending on the location within 
the parenchyma of the spinal cord (Keeler BE 2012).  Table 1 summarizes the findings of 
recent experiments to facilitate comparison of these results. 
We found TrkA expression increases in both the DRG and spinal cord of animals 
after contusion in a manner that was dependent on injury severity.  This finding is of 
particular interest with regards to the functions of NGF and TrkA.  NGF plays a well-
defined role in sensitization of nociceptive afferent neurons (Shu X 1999; Shu X 2001; 
Galoyan SM 2003; Zhu W 2004).  Nociceptive DRG neurons undergo changes after SCI, 
including development of spontaneous activity (Bedi SS 2010) and an enhanced intrinsic 
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growth promoting state (Bedi SS 2012).  Such changes in anatomical and physiological 
properties of nociceptors may contribute to development of conditions such as autonomic 
dysreflexia (Marsh DR 2002)).  TrkA antagonists prevent the sensitization (thermal and 
mechanical hyperalgesia) normally induced by partial nerve injury (Ma WY 2010), and 
antagonism of TrkA signaling has been effective for controlling human pain (Mantyh PW 
2011). Hence, elevation in the levels of TrkA and NGF in response to contusive injury 
could play a role in some of the maladaptive processes after incomplete SCI. 
TrkB activation has also been implicated in hypersensitivity to nociceptive input 
and sensitization of nociceptors (Kerr BJ 1999; Shu XQ 1999; Garraway SM 2003).  
However, after either SC transection or contusion injury, BDNF induced facilitation of 
afferent responses in lamina II of the dorsal horn is significantly reduced (Garraway SM 
2005; Garraway SM 2007).  Our results could suggest a mechanism for those 
physiological observations.  In addition to TrkB expression in populations of second 
order nociceptive neurons (Schober A 1999), it is expressed robustly throughout the 
interneuronal circuitry, and also co-expressed along with NT3 in motoneurons (Buck CR 
2000), a finding corroborated in humans (Josephson A 2001).  Notably, BDNF 
administration to the injured spinal cord can improve locomotor outcomes, however 
because of its influence on nociceptive circuitry its therapeutic utility may be limited 
(Boyce VS 2012).   
In DRG, TrkC is present on medium to large diameter muscle spindle afferents 
that make monosynaptic connections with motoneurons and cutaneous low threshold 
mechanoreceptors (Klein R 1994; Oakley RA 1997; Josephson A 2001) in the 
intermediate and ventral horns of the spinal cord.  NT3, likely acting via TrkC, can exert 
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a modulatory effect on sensorimotor circuits in both intact (Petruska JC 2010) and injured 
preparations (Mendell LM 2001; Arvanian VL 2003; Arvanian VL 2006; Arvanian VL 
2006; García-Alías G 2011; Schnell L 2011).  Locomotor training after spinal cord injury 
is associated with increased expression levels of TrkB and TrkC agonists in rats 
(Hutchinson KJ 2004; Côté MP 2011). In addition, co-administration of both BDNF and 
NT3 to the injury site has been shown to improve hindlimb locomotion after transection 
in both rats (Blits B 2003) and cats (Boyce VS 2007).  Taken together, these findings 
suggest a potential role for Trk activation in modulation of lumbar sensorimotor circuitry 



























NEUROTROPHINS AND AGING IN THE SPINAL CORD 
4.1 Introduction 
The apparent age-related regulation of NGF, BDNF, and NT3 in non-injured 
spinal cord was unexpected and we made significant efforts to identify possible technical 
and sampling issues. While those factors that often account for variability did not 
satisfactorily account for the expression patterns we observed, the single factor of age did 
appear to fully account for the differences. Expression of the neurotrophins has been 
examined in the context of embryonic and postnatal development and in aging (e.g., 
(Timmusk, Belluardo et al. 1994; Nosrat 1998; Bergman, Ulfhake et al. 2000). However, 
to the best of our knowledge, there has been no systematic assessment of the regulation of 
the neurotrophins at such late postnatal times, leading us to postulate that perhaps there 
was a previously undocumented age related decrease in neurotrophin expression that 
persisted throughout the lifespan of the adult rat. 
 Much of the literature concerning neurotrophins and aging comes from 
assessments of expression levels in the forebrain. In the cortex and hippocampus, the 
mature form of NGF levels decrease relative to age in naïve animals, while BDNF levels 
remain unchanged (Perovic, Tesic et al. 2012).  However, other studies that sampled 
multiple areas throughout the forebrain and also the sciatic nerve found no significant 
difference in levels of NGF, BDNF, or NT3.  These changes appear to be region specific 
however, as increases in the levels of BDNF in the hippocampus, as well as increases in 
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levels of NT3 in the cerebral cortex have been documented(Katoh-Semba, Semba et al. 
1998). Thus, we sought to determine whether the changes we observed from 6 to 12 
weeks in the spinal cord were due to regional specificity within the spinal cord and 
whether these changes persisted throughout the lifespan of the adult rat 
 
4.2 Results 
4.2.1 Expression of NGF, BDNF, and NT3 at 3, 6, 9, 12, and 15 months after birth in 
the uninjured rat spinal cord 
 Unlike the decreases that we observed for all neurotrophins from 3 to 6 months in 
the adult rat, these changes did not persist throughout the course of adulthood based on 
further analysis at 9, 12, and 15 months after birth (NGF Fig 11, BDNF Fig 12, NT3 Fig 
13). The only significant change in the levels for any of the neurotrophins was an 
increase in the levels of NT3 at 9 months after birth, above the levels of 3 and 6 month 
uninjured rats (Fig 13). 
 
4.3 Discussion 
 Though the observation that the trend of decreasing expression did not persist 
through the lifespan of the adult rat was somewhat surprising, there are several factors 
that provide rationale for the explain differences we observed. The animals we used at 
our 9 and 15 month time points had been used for the purpose of breeding and were 
housed at a different location.  This could have resulted in several differences between 
these animals and the animals used for the 3, 6, and 12 month after birth groups. One was 
simply that the 9 and 15 month groups had been pregnant. During pregnancy, uterine 
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receptivity to implantation is dependent on levels of progesterone (Bazer, Burghardt et al. 
2008). Progesterone plays a role in neuroprotection via regulation of BDNF (Su, 
Cunningham et al. 2012; Singh and Su 2013). Progesterone has also been shown to 
maintain levels of NGF (Tometten, Blois et al. 2005), thus a putative link between 
neurotrophins and hormones regulated during pregnancy is plausible. Another difference 
between the groups of rats were the environments in which they were placed. 
Additionally, environmental enrichment in the adult rodent nervous system has been 
shown to protect the brain from age-related dysfunction, which can be accomplished 
through induction of NGF (Mohammed, Henriksson et al. 1993) and BDNF (Cirulli, 
Berry et al. 2010) expression, and could also play a role in regulation of neurotrophin 
levels. Though these mechanisms might certainly be involved, the observation that no 12 
and 15 month after birth groups differed in their expression levels (12 month animals 
were conditioned in a similar environment to the 3 and 6 month groups, and did not give 


















COORDINATED EXPRESSION OF NEUROTROPHINS AND TRK 
RECEPTORS IN DRG AT 12 WEEKS POST INJURY 
5.1 Introduction 
 12 weeks after injury there were analogous increases in the NGF and NT3 from 
the expression levels we observed at our 6 weeks time points. Since all assessments were 
obtained from samples that were derived from the same animals, we sought to determine 
whether these increases extended concomitantly within each sample. Thus, we next 
calculated the correlation coefficient between all neurotrophins(i.e. NGFvNT3, 
NGFvBDNF, BDNFvNT3), their Trk receptors(i.e. TrkAvTrkC, TrkAvTrkB, 
TrkBvTrkC), and between each neurotrophin ligand and its cognate receptor(NGFvTrkA, 
BDNFvTrkB, NT3vTrkC).  Such interactions that regulate expression levels of different 
neurotrophins have been reported in different cellular and animal models previously 
(Leingärtner A 1994; Canossa, Griesbeck et al. 1997; Gratto and Verge 2003; Mallei, 
Rabin et al. 2004; Kuo, Groves et al. 2007), however none have investigated whether 
such patterns emerge between all neurotrophins and Trk receptors at more chronic time 







 5.2  Results 
To further characterize the relationship between the neurotrophins and their receptors in 
lumbar DRG and spinal cord, we analyzed the expression levels of neurotrophins and Trk 
receptors relative to each other, and without respect for injury severity. In the spinal cord, 
the only significant relationship was that of TrkB and TrkC in the control and 6 week 
groups.  No relationship was found between any other expression levels at any time 
points in the spinal cord (Table 2).  In the DRG, there was a relationship between NGF 
and NT3 in all groups. In the 6 week groups the only other significant correlation 
observed was between BDNF and TrkB.  After 12 weeks there was a significant 
correlation in the expression levels of all neurotrophins in the DRG, a relationship that 
existed for the Trk receptors as well (Table 3). Additionally, a significant correlation was 
observed between expression levels of neurotrophins and their cognate Trk receptors at 
12 week time points (Table 3). This coordinated expression pattern occurred in all 
animals independent of injury severity (Figures 14 & 15). The reliability of this statistical 
assessment is enhanced by our performing the reverse-transcription for all samples with 
the same reagents, a procedure which reduces the cross-sample variability. 
 
5.3 Discussion 
12 weeks post injury a coordinated expression pattern emerged when comparing 
all neurotrophins and Trk receptors to one another. This pattern was independent of 
injury severity, and was also present between the neurotrophins and their cognate Trk 
receptors in the DRG (Tables 1and 2, fig’s. 5 and 6), a relationship that was not evident at 
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6 weeks post-SCI, nor for expression levels in the SC. Although there are reports of 
smaller groups of neurotrophins and/or Trks being regulated in a coordinated fashion 
(Widenfalk, Olson et al. 1999), to our knowledge this degree of coordination has not been 
reported. One obvious possibility is a feedback/feedforward relationship between 
some/all of these genes, and these sorts of relationship do exist (Michael, Averill et al. 
1997; Wyatt, Middleton et al. 1999; Gibbons and Bailey 2005). 
Neurotrophin dependent neurotrophin expression has been demonstrated in vitro 
in NIH3T3 and PC12 cells (Canossa M 1997; Mallei A 2004), hippocampal neurons 
(Canossa M 1997), and cerebellar granule neurons (Leingärtner A 1994).  In vivo, 
intrathecal administration of NT3 to intact adult animals for one week results in reduced 
expression of TrkA protein in the DRG, but has no effect on levels of TrkC (Gratto KA 
2003).  After unilateral axotomy, sub-cutaneous administration of exogenous NT3 
similarly causes a decrease in TrkA on the side contralateral to the injury.  This contrasts 
to the increase in TrkA expression seen on the side ipsilateral to the injury; the effect of 
NT3 on expression levels of TrkB and TrkC however is not affected by injury in this 
paradigm, as levels of these transcripts show increased expression up to 4 weeks post 
axotomy in both ipsi- and contralateral DRG (Kuo LT 2007).  Such coordinated 
expression patterns could result from changes at the epigenetic level or from potentially 
from interactions between the different transcription factors associated with expression of 
specific transcripts.   
In (Hougland et al. 2012), bioinformatic analyses were performed in an attempt to 
elucidate potential underlying factors involving miRNA and common transcription 
factors that may underlie the expression patterns that were observed between 
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neurotrophins/Trks. Though no common miRNA targets were revealed through a 
TargetScan analysis of 3’-UTRs, this was likely due to the search criteria inherent in the 
bioinformatic platform that was used. TargetScan only retrieves targets that have been 
experimentally confirmed, thus the absence of a finding likely reflects a lack of preceding 
investigations into the subject rather than simply a negative finding. Likewise, in 
searching for common transcription factors that regulate expression of these genes, no TF 
was retrieved that involved regulation of TrkC. This was due to stringent filtering 
processes that relegated all returned queries to those validated as being expressed in the 
nervous system (Hougland, Harrison et al. 2012).  Despite the exclusion of TrkC as a 
result of this filtering process, TrkC has several well established transcription factors that 
play a role in determining its expression in the nervous system, notably; Runx3 
(Levanon, Bettoun et al. 2002), Runx1, Brn3a, (Zou, Li et al. 2012)and REST (Nakatani, 
Ueno et al. 2005). 
During development, Runx1 and Runx3 transcription factors play essential roles 
in cell fate determination of nociceptive (Chen CL 2006) and proprioceptive (Inoue K 
2002) neurons, respectively.  Much attention regarding transcriptional regulation of 
neurotrophin expression in the mature nervous system has been given to BDNF, due to its 
role in activity dependent mechanisms during long-term potentiation (LTP).  Such 
investigations have revealed several important transcriptional regulators including; cyclic 
AMP response element binding protein (CREB), calcium-responsive transcription factor 
(CaRF), and methyl CpG-binding protein 2 (MeCP2) (Tao X 1998; Tao X 2002; Chen 
WG 2003; Reichardt LF 2006).  Such findings may facilitate future efforts to determine 
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the mechanisms regulating the expression of the neurotrophins and Trk receptors in the 
injured adult spinal cord and sensory ganglia. 
Despite the absence of TrkC from the analysis, (Hougland et al 2012) identified 4 
TFs that potentially interacted with the entire set of remaining genes. The majority of 
literature regarding these TFs and their involvement in regulation of neurotrophins and 
Trks is in the context of development or cancer. Accordingly, the authors could not 
identify any studies examining Pax3, NeuroD, or MafB in spinal cord or DRG in the 
context of SCI. Maf has been studied in relation to neurodegeneration (Kobayashi, 
Tsukide et al. 2011) and in stress (Machiya, Shibata et al. 2007). Pax3 was studied in 
relation to nerve injury, where it was found to not be regulated (though this does not 
imply it not being active) (Vogelaar, Hoekman et al. 2004). 
There are studies examining CREB in spinal cord (Canossa, Griesbeck et al. 
1997; Copray and Kernell 2000; Crown, Ye et al. 2006; Cote, Azzam et al. 2011) or DRG 
(Qiao and Vizzard 2005) in the context of SCI, with the latter study examining the TrkA, 
TrkB, and CREB, though not in direct relation to each other. Interestingly, the expression 
of activated CREB in the DRG changed over the course of the first 6 weeks after SCI, 
with the levels at 6 weeks being significantly greater than controls, though not in the 
DRG we examined here. After a conditioning lesion to the peripheral nerve, enhanced 
regeneration of the central branches can be observed and is dependent on elevation of 
cAMP within the DRG. (Neumann, Bradke et al. 2002; Yang and Yang 2012)Other 
studies demonstrate induction of CREB in injured/stressed neurons and also in neurons 
post-synaptic to stressed sensory neurons (Ji and Rupp 1997; Bedogni, Pani et al. 2003; 
Choi, Kim et al. 2003; He, Csiszar et al. 2003; Zhu, Lau et al. 2004), while others 
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demonstrate CREB regulating multiple NTs (Bender, Lauterborn et al. 2001), in at least 
one case by interacting with cytokines (Otten, Marz et al. 2000). 
 Our data was derived from homogenized tissue, thus we cannot make conclusions 
about apparent coordinated expression on the basis of individual cells, though we can 
draw from a number of sources to make inferences about what may potentially be 
happening.  
1) There is some evidence that at 6 weeks after SCI trk receptors are expressed 
almost exclusively in DRG neurons, similar to before the SCI (Qiao and 
Vizzard 2002; Qiao and Vizzard 2005). However, it must be noted that there 
is a wealth of evidence that suggest expression of NTs and Trks in non-
neuronal cells (e.g., (Funakoshi, Frisen et al. 1993; Elkabes, Peng et al. 1998; 
Nemoto, Fukamachi et al. 1998; Noga, Englmann et al. 2002; Hess, Scott et 
al. 2007), although much of this is in the context of cancer (e.g., (Tacconelli, 
Farina et al. 2005; Howe, Cochrane et al. 2011; Jin, Lee et al. 2011). Studies 
which identify the cell types expressing the NTs or Trks are necessary as it is 
possible that at least a portion of the tissue-level regulation could be due to 
invading cells. Certainly the complement of immune cells in the spinal cord 
is affected by injury, even in segments spatially remote from the injury (e.g., 
(Popovich, Wei et al. 1997). Immune cells invade the DRG after nerve injury 
(e.g., (Nguyen, O'Barr et al. 2007; Vega-Avelaira, Geranton et al. 2009; Kim 
and Moalem-Taylor 2011), but this possibility has not been examined in 
DRG at any time after SCI. However, evidence suggests that the immune 
cells and their functions throughout the body may be affected by SCI (e.g., 
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(Popovich, Stuckman et al. 2001), and some express Trk receptors and/or 
neurotrophins (e.g., (Noga, Englmann et al. 2002; Nassenstein, Kerzel et al. 
2004; Tabakman, Lecht et al. 2004). 
2) There are certainly studies which examine the chronic post-SCI condition, 
but we could not identify any that could provide data relevant to these 
specific considerations (i.e., they examined other readouts). 
 Almost irrespective of the outcome of the above considerations, there is still 
another consideration that can be brought to bear. Although there are papers describing 
co-expression of some of these genes in single cells where common genetic/molecular 
regulation could possibly be at play, it is highly unlikely that all the coordinated 
expression is accounted for by single cells. Even in the condition where expression is 
limited to neurons, and even to the same population of neurons that expressed these genes 
in the intact system (i.e., differences in expression would be based on volume regulation 
in any given cell and not on recruitment/de-recruitment of cell populations), what is the 
likelihood that this degree and scope of coordinated expression could occur across 
different cell types independently? It seems unlikely that each of the genes considered 
would change in a single cell type independent of its regulation in any other cell type, and 
still display such relatively similar expression levels. However, because there is little-to-
no cellular expression data here or in the literature from which to extrapolate the identity 
of the cells expressing these genes (i.e., immunocytochemical or in situ hybridization 
assessment of DRG 12 weeks post-SCI), we must acknowledge that this is possible. 
There is, however, virtually no reason to expect that individual cells would express all of 
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the “coordinated” genes and thus have the mechanism of coordinated regulation exist 
fully inside of those given single cells. Therefore, at least some of the coordination must 
arise across cells which express one or more of the “coordinated” genes, thought whether 
this is due to the protein products of the genes themselves or an outside factor is unclear.  
 Additionally, there might also be a shared biological process(es) or response(es) 
being executed in various different cells – a process that has similar outcomes in terms of 
gene regulation but arrives there through actions of different specific molecular entities. 
For “simplicity”, let us consider that only the neurons of the DRG are involved. Even this 
cell population is not homogeneous in function, form, or sensitivity. Each of the Trk 
receptors is expressed largely in separate subpopulations. Given the dissimilarities of 
their regulatory sequences, they may each be directly regulated by distinct factors. 
However, conditions may arise that induce the non-homogeneous neuronal types, 
regardless of the specific trk they express (and thus which specific factors will act on the 
DNA and/or mRNA), to coordinately regulate the expression of their trk receptor. It is 
possible that the regulation of those specific factors may be under a control mechanism 
that is itself shared across the different neuron types. Our analysis would not detect this. 
As an example, consider cellular stress or injury. Numerous authors have reported on the 
regulation of Trks and neurotrophins in response to nerve injury, and the change in 
expression over time (Ernfors, Rosario et al. 1993; Sebert and Shooter 1993; Krekoski, 
Parhad et al. 1996; Yamamoto, Sobue et al. 1996; Bergman, Fundin et al. 1999; Lee, 
Zhuo et al. 2001; Kuo, Groves et al. 2007), and many aspects of our data agree with 
reported regulation after nerve injury or neuronal stress. Intriguingly, there was another 
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report of “coordinated regulation” associated with DRG neurons and glia in conditions of 
injury and/or stress (Cameron, Vansant et al. 2003).  
  Presently it is unclear whether SCI induces any long-term injury or stress on DRG 
neurons. Certainly the central axons of some DRG neurons are damaged in SCI, 
particularly those terminating in the affected cord, or with long axons ascending through 
the dorsal columns (Huang, Robson et al. 2006). However, effects of injury to central 
axons differs from those of injury to peripheral axons (Stam, MacGillavry et al. 2007), 
and the long-term effects on expression of neurotrophins and trk receptors has not been 
examined. Injury to central axons is not the only possible source of stress to sensory 
neurons, however. The inflammatory condition of the spinal cord and continued spread of 
damage may induce injury or stress in sensory neurons at times remote from the acute 
SCI, and at locations remote from the lesion (Popovich, Wei et al. 1997; Popovich 2000; 
Bao, Chen et al. 2004; Fleming, Norenberg et al. 2006; Gris, Hamilton et al. 2008; Kwon, 
Stammers et al. 2010; Bao, Brown et al. 2011; Lubieniecka, Streijger et al. 2011; Ng, 
Stammers et al. 2011; Stammers, Liu et al. 2012). There is a systemic inflammatory 
condition (Fleming, Norenberg et al. 2006; Gris, Hamilton et al. 2008; Bao, Omana et al. 
2012) that has unknown effects on these neurons. Additionally, one must consider the 
effects of SCI on peripheral tissues innervated by sensory and motor neurons. The 
inflammation and altered activity/mobility/use state can impact these tissues (Edwards-
Beckett and King 1996; Lynch, Anthony et al. 2000; Gris, Hamilton et al. 2008) with 
uncertain consequences for the innervating neurons. The increased expression of galanin, 
a neuropeptide induced in DRG neurons by stress/injury (Suarez, Guntinas-Lichius et al. 
2006), in the DRG innervating bladder and bowel (but not other DRG) after SCI 
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(Zvarova, Murray et al. 2004) suggests that the histopathology secondary to SCI may 
stress the sensory neurons innervating those tissues. Tissue damage has been shown to 
induce stress/injury responses in sensory neurons (Ivanavicius, Ball et al. 2007; Hill, 
Harrison et al. 2010; Thakur, Rahman et al. 2012), and has been shown to affect 


























EXPRESSION OF INFLAMMATORY MARKERS AFTER SCI 
6.1 Introduction 
 Cytokines such as IL-6 have been shown to induce expression of NGF, NT4/5, 
and NT3 from cultured astrocytes (Otten, Marz et al. 2000). In rodents after injury, IL-6, 
IL-1α, IL-1β, IL-13, CCL2, MIP1α, RANTES, and TNFα are elevated acutely in the 
spinal cord(Stammers, Liu et al. 2012). In humans, protein levels measured from CSF of 
injured patients indicate that assessment of some of the same molecules can serve as a 
biomarker for injury severity, including IL-6, IL-8, CCL2, tau, S100beta, and glial 
fibrillary acidic protein(Kwon, Stammers et al. 2010).  Based on the data presented in the 
previous chapters, we deduced several scenarios that could be at play. It is possible that 
neurotrophins alone could be regulating their own expression and that of Trk receptors. 
We also considered, based on the data mentioned above, that a common factor or 
mechanism might be influencing expression, such as infiltration of immune cells 
expressing inflammatory cytokines, or simply cytokines endogenously expressed by cell 
types resident within the nervous system. 
To investigate whether a cytokine/receptor or other inflammatory molecule is 
responsible for the expression patterns observed among the set of neurotrophins/Trks, we 
limited our targets to a specific (and partially overlapping) subset of factors that we felt 
represented a broad range of molecules involved in these processes. These included: IL6, 
LIF, and CNTF, a related set of ligands that bind the common GP130 co-receptor(a 
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molecule which was also included), the cytokine TNFa, iNOS, a protein that is induced to 
form Nitric Oxide as an immune defense mechanism, CD11b, an integrin present on the 
surface of leukocytes that mediates immune cell adhesion, Interferon gamma and the 
chemokine CCL2(aka MCP1). 
 
6.2 Results 
6.2.1 Gene targets without appreciable expression levels 
 Several of the genes we chose to investigate were not expressed to detectable 
levels in the DRG.  All reactions were run in duplicate, and the criteria for detectable 
gene expression was when more than one of the samples(1 set of duplicates) within more 
than one of the 6 groups(6wk control, both 6wk injury groups, 12wk control, and both 
12wk injury groups) failed to reach the Ct threshold for the gene of interest.  The genes 
included in this list are: IL6, IL10, iNOS, and Interferon gamma (data not shown). 
 
6.2.2 Gene targets whose controls were unchanged from 6 to 12 weeks 
 Genes that were expressed at appreciable levels were divided into two groups 
depending on whether or not expression of their control groups changed significantly 
from 6 to 12 weeks post surgery. There were four genes that had no change in the control 
groups from 6 to 12 weeks; CD11b, LIF(Fig 16), TNFa in DRG and SC(Fig 17), and 
gp130. Of these four genes, only gp130 showed any significant changes. For gp130, in 
the 12.5gcm 12 weeks post injury, expression levels were elevated significantly above the 
control group, as well as both of the 25 gcm injury groups. In animals that received a 25 
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6.2.3 Gene targets whose controls changed from 6 to 12 weeks 
 Genes that had changes in the expression of controls from 6 to 12 weeks were 
CNTF and CCL2. For CNTF, all 12 week groups showed a significantly increase relative 
to the 6 wk control and 6 wk 12.5 gcm groups. However, since controls increased from 6 
to 12 weeks, it also helps to assess levels relative to time matched control. If this is done, 
the 6 wk 25gcm group is significantly above the 6 wk control group, while all other 
relative expression levels are not significant. (Figure 19) For CCL2, control expression 
levels decreased from 6 to 12 weeks, but in contrast the injury groups were substantially 
increased. (Fig 20)  
Note: Figure 21 and 22 for discussion purposes 
 
6.3 Discussion 
Interleukins are cytokines that exhibit a diverse array of effects across different 
cell types and tissues (Brocker, Thompson et al. 2010). Interleukins can exert both pro- 
and anti-inflammatory effects, and serve to activate and modulate differentiation of 
immune cells in response to inflammation (Commins, Borish et al. 2010). IL6 belongs to 
a family of cytokines that have a broad range of effects stemming from their various roles 
in inflammation, immune response, and cell survival and differentiation (Jazayeri, Carroll 
et al. 2010), and can be further characterized based on whether or not they are 
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biologically active as monomers or heterodimers. Those of the monomeric subdivision 
bind through the common co-receptor subunit gp130 (also known as IL6ST) (Boulay, 
O'Shea et al. 2003; Heinrich, Behrmann et al. 2003), which also includes(among others) 
LIF and CNTF. LIF signals through gp130 in combination with LIF receptor (LIFR) 
(Plun-Favreau, Perret et al. 2003), while CNTR signals through a heterotrimeric complex 
that includes both gp130 and LIFR as well as the CNTF receptor (CNTFR) (Stahl and 
Yancopoulos 1994). 
Expression of IL6 can be stimulated through signaling complexes of other 
cytokines such as TNFa, IL1, and LIF, as well as in an autocrine fashion. This occurs 
through binding of nuclear factor IL6 (NF-IL6) to an IL1-responsive element within the 
IL6 promoter (Akira, Isshiki et al. 1992), and also activates transcription through 
phosphorylation of STAT3 tyrosine kinase (Akira 1997). In contrast to IL6, IL10 is 
biologically active as a homodimer and acts through the JAK/STAT pathway to suppress 
expression of pro-inflammatory cytokines, and is thus an important anti-inflammatory 
molecule (Murray 2007). These cytokines, along with the evolutionary related 
Interleukins in both of their family, are expressed by white blood cells in response to 
infection and injury (Dinarello and Mier 1986). In addition, CD11b is an integrin 
expressed on the cell surface of white blood cells that mediates adhesion and migration of 
leukocytes (Solovjov, Pluskota et al. 2005). They are important mediators of the immune 
response and are highly expressed after insult to the body, thus due to the lack of 
expression (or change in expression in the case of CD11b) we observed, it is unlikely that 
the infiltration of white blood cells that express these molecules into the DRG can explain 
the patterns of expression that were observed in our previous studies.  Despite our data 
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suggesting that the IL6 cytokines that are biologically active as monomers and TNFa do 
not appear to be responsible for the expression pattern of neurotrophhins 12 weeks post 
SCI, we did not investigate the IL6 cytokines biologically active as heterodimers, nor did 
we investigate other Interleukins or cytokines. Since these molecules comprise expansive 
families of molecules that mediate immune response in a wide variety of ways, our 
analysis is by no means exahaustive.  
IL6, LIF, and CNTF have differing effects on the survival of cultured newborn rat 
DRG neurons. Specifically, both CNTF and LIF are able to promote survival of these 
neurons (Simon, Thier et al. 1995), and enhances neurite outgrowth in both large 
diameter and small diameter cells of the DRG, while IL6 does not (Sango, Yanagisawa et 
al. 2008).  This finding however, is likely due to the IL6 receptor not being sufficiently 
expressed at this developmental stage, as supplying both the IL6 ligand and soluble 
receptor does support survival (Thier, Marz et al. 1999).  In vivo, CNTF is expressed by 
Schwann cells, and after peripheral nerve injury is released to promote axonal 
regeneration and neuron survival. However, when primary DRGs are explanted and 
cultured, neurons begin to also express CNTF, which is localized to both the soma and 
dendrites (Sango, Yanagisawa et al. 2007). This could be due either to disruption of cell-
cell contact, or potentially a response to injury by the explanted neurons. We observed 
that CNTF levels were elevated above that of controls 6 weeks post injury in a 
moderately severe (25 gcm) contusion.  However, though the expression levels of both 
the 12 week control and injury groups are elevated above controls in the 6 week post 
injury groups, CNTF levels returned to that of controls by 12 weeks post injury relative 
to the time matched control. Thus, the increase in CNTF seen at 6 weeks does not persist, 
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and the further increase in CNTF expression above 6 week levels is likely only a function 
of aging, a finding that is supported in previous literature (Nakamura and Bregman 
2001).  
Our investigations of inflammatory markers that potentially influence expression 
of the neurotrophins and their Trk receptors targeted three groups of molecules that serve 
separate, yet overlapping functions: cytokines, interferons, and chemokines. Cytokines 
mediate growth, differentiation, and activation during an immune response. This 
contrasts with chemokines, which serve to direct immune cells to sites of inflammation 
via chemotaxis; and inteferons, which directs cellular responses to viral infections 
(Commins, Borish et al. 2010).  Interferon gamma was the only interferon that was 
assessed, due to its important role in cell-mediated immunity (Farrar and Schreiber 1993), 
and had undetectable levels of expression. The only chemokine (White, Sun et al. 2005) 
assessed was Chemokine ligand 2(CCL2), also known as Monocyte Chemotactic 
Protein(MCP1). Expression of CCL2 was essentially the same as control at our 6 week 
time point, but at 12 weeks post injury had risen to approximately 8 times the level of the 
control group in both injury severities. CCL2 leads to hyperexcitability of DRG neurons 
both in culture and in vivo (White, Sun et al. 2005).  Additionally, many models of 
neuropathic pain induce potent expression of CCL2, (Tanaka, Minami et al. 2004; Jeon, 
Lee et al. 2008; Bhangoo, Ripsch et al. 2009; Jeon, Lee et al. 2009; Foster, Jung et al. 
2011) and knockout mice lacking its receptor CCR2 (Abbadie, Lindia et al. 2003),  or 
pharmacological blockade (Serrano, Pare et al. 2010) impairs the development of 
neuropathic pain. This hyperalgesic response is due to upregulation of the current density 
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and expression of TRPV1 (Kao, Li et al. 2012) and Nav1.8 (Belkouch, Dansereau et al. 
2011). 
In the rodent and human spinal cord, CCL2, along with several other 
inflammatory cytokines, can be used as a correlative biomarker for injury severity 
(Kwon, Stammers et al. 2010; Stammers, Liu et al. 2012).  We observed that CCL2 was 
upregulated in our 25 gcm group at 12 weeks post-injury. Though the discrepancy 
between our findings and that of the previous studies is unclear, there are a number of 
parameters that were different between the experiments. In the previous rodent studies, 
the time points assessed only extended to 24 hours post injury. Though a contusion injury 
was also used for the purposes of their studies, the injury was performed using the OSU 
impactor rather than the NYU device.  As shown earlier, not only can the type of 
contusion effect the levels of expression but even the severity within the same type of 
injury model. These previous also assessed protein levels, whereas only mRNA was 
examined for the purposes of our study. In terms of the human study, protein levels were 
also examined, though from the CSF and the blood serum, and the time period was up to 
72 hours post injury. These vastly different time points and methods of injury very likely 
















 Through our characterization of neurotrophins and their Trk receptors we found 
that from 6 to 12 weeks post-contusion there were differences in the mRNA expression 
levels of these molecules, and this difference was dependent on the severity of the 
contusion. Based on previous data that use different models of spinal cord injury and 
assess neurotrophin/Trk levels at various times (Table 1), the observation that there is an 
injury severity dependent difference in expression of individual transcripts is not 
surprising. This highlights the importance of characterizing any experiment in terms of 
injury model, time point, and injury severity. However, it nevertheless elicits the question 
of why the difference exists? One explanation is that there are different levels of activity 
below the level of the injury. It is feasible to think that differing levels of descending 
input(based on which fibers are spared) lead to concomitant changes to the motoneurons 
basal levels of excitability, perhaps through remaining monoaminergic synapses 
(Heckman, Lee et al. 2003; Anelli, Sanelli et al. 2007; Murray, Stephens et al. 2011).  
This could in turn result in tonic levels of muscle activity and subsequent levels of 
afferent activity that are affected relative to the amount of spared descending input. 
 Another possibility is that the nervous system is reacting to the injury by 
regulating certain plasticity-inducing factors. Operating under this notion, there are 
several scenarios that one could use to explain these observations, 1) such factors could 
be regulated in a manner meant to achieve the degree of homeostatic plasticity (aka 
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“normalcy”) that was present in the circuitry before the injury 2) such factors could be 
regulated based on the capacity for the circuitry to achieve a certain degree of 
homeostatic plasticity(that is, based on severity of the injury and how well the animal(s) 
recovered).  If the former is the case, then one would expect that the further the animal is 
from how it functioned before the injury (i.e. more severely injured), the more highly a 
plasticity inducing molecule would have to be expressed to achieve the level of pre-injury 
function. If the latter is the case, then one would expect essentially that the higher the 
capacity for functional recovery (i.e. less severely injured), the higher the level of 
expression of these plasticity-inducing factors.  
 It is important to note, that the “factors” being referred to could either be the 
neurotrophins/Trks themselves and/or some other molecule that regulates expression of 
all the neurotrophins/Trks. If it is a single neurotrophin, the prime candidate would be 
NT3, as it is the only neurotrophin that has been shown to be able to bind to and activate 
all three Trk receptors (Davies, Minichiello et al. 1995). If it is all the neurotrophins, then 
it would likely be acting through the pan-neurotrophin receptor p75 (Dechant, Rodriguez-
Tebar et al. 1994). There is also the possibility that it is not the neurotrophins acting 
through Trks or p75, but through a separate signaling mechanism that acts on all 
subclasses of neurons in the DRG that express neurotrophins/Trks and accordingly 
coordinates levels of expression, such as an inflammatory mediator.  Indeed, 
inflammatory molecules such as TNFalpha and IL6 have been suggested to be associated 
with NGF (Woolf, Allchorne et al. 1997) and BDNF (Lin, Ro et al. 2011) mediated hyper 
excitability of DRG neurons in models of neuropathic pain. The observation that CCL2 is 
drastically upregulated at 12 weeks is particularly interesting, given that CCL2 can effect 
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DRG neurons of all sizes (i.e. large, medium, small) (White, Sun et al. 2005), which 
theoretically encompasses all subpopulations of neurons that express Trk receptors in the 
DRG.  Finally, these putative interactions could be occurring synergistically, such that an 
external factor initiates a particular expression pattern which is then overtaken by 
neurotrophin/Trk mediated neurotrophin/Trk expression in a feed-forward manner, or 
vice versa.  
 Upon further analysis, by calculating the correlations between expression levels 
of the different neurotrophins and Trks in the context of each individual animal, we were 
able to uncover what appears to be a coordinated pattern of expression that exists among 
the neurotrophins and Trk receptors in the DRG (but not spinal cord) at 12 weeks (but not 
at 6 weeks) post injury.  This pattern was independent of injury severity (i.e. expression 
values were correlated between all molecules regardless of whether the injury was 
12.5gcm or 25 gcm). Furthermore, we investigated expression of cytokines as potential 
elements involved in the changes we observed, and  identified elements that were 
regulated in either a time(i.e. CCL2) or injury severity dependent (i.e. gp130) fashion. 
Based on these assessments, future investigations into the cause(s) of initiation of these 
mechanisms will be better informed as to what might or might not be a useful starting 
point.  
 The finding that at 12 weeks there was a coordinated expression pattern in the 
DRG that was independent of injury-severity while certain transcripts increase (i.e. TrkA) 
from 6 to 12 weeks, but other transcripts decrease (i.e.TrkB), warrants further 
clarification. Why is this happening? More specifically, what is causing a different 
direction of change in one versus the other if they are eventually being regulated in an 
54 
 
analogous manner in the different constituent subpopulations of neurons? One possibility 
is that each set of neurotrophin/Trk receptor has an initial response to loss of descending 
input/alteration of afferent input acutely (i.e. TrkB increases, TrkA decreases), from 
which it is still “recovering” at 6 weeks, that by 12 weeks has been overtaken by a 
differing response. Such a response could be activity- or factor-dependent (or both) in 
such a way that modulates their expression in a manner that dictates when expression of 
one of these molecules (neurotrophin, Trk) is relatively low/high in the DRG of a certain 
animal, that the other molecules of their family (neurotrophin, Trk) is relatively low/high 
as well. It is also possible that both are active at the same time, with a more robust 
response that masks the effect of the other until the initial robust response becomes 
inactive and thus the other becomes more apparent.  
 The coordinated expression pattern can also be understood as a predictive factor 
that, given a set of data, one could deduce which animal expressed a certain level of a 
neurotrophin/Trk based on the expression level of another neurotrophin/Trk. For 
example, view the range of all injured animals at 12 weeks post injury and their TrkA 
expression values as lying on a spectrum from low to high. When compared with the 
highest value from NGF, BDNF, NT3, TrkB, and TrkC, the highest expression in 4 of 5 
of these molecules are from the same animal as that for TrkA. Though it might be useful 
for one to view the coordinated expression pattern in this way to aid conceptualization, it 
is important to note that the predictive power of any given point is directly related to the 
correlation coefficient between two sets of molecules, and since none of the coefficients 
were 1, this is not an absolute predictor (as demonstrated above). 
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 Due to the finding that control levels of certain genes changed between 6 and 12 
weeks, plots were constructed for display purposes and to identify any robust trend that 
might have been occurring that our statistical analyses failed to elucidate. These analyses 
failed to uncover any novel findings, but served to demonstrate that there was a higher 
degree of variability in neurotrophin expression than Trk receptor expression (Fig 21 and 
22). Subsequent power analysis was performed post-hoc to determine the ideal group size 
based on the average means and variability for all neurotrophins and Trk receptor 
transcripts assessed. These analyses revealed that had we used an n of 12 for all groups, 
we would perhaps have also found changes between groups relative to both injury 
severity and survival time in the following analyses: TrkC in the DRG, NT3 in the DRG, 
TrkB in the DRG, TrkA in the spinal cord, and TrkA in the DRG. 
 Severalother factors that could have influenced the results we observed warrant 
further consideration. For instance, as the animals that were used in this experiment were 
all females, it is important to note that the potential role of the estrous cycle was not 
investigated. (Baker and Hagg 2005) found that after spinal cord contusion, the stage of 
the estrous cycle did not affect sensory axon degeneration, though neurotrophin levels 
were not examined. Investigations of the role of estrous cycle on neurotrophin/Trk 
receptor levels have been performed primarily in the hippocampus. In one study, it was 
shown that TrkA fluctuates by as much as 16-fold during proestrous in reactive 
astrocytes. This effect was not observed in rats that were ovariectomized, however with 
reintroduction of estrogen, TrkA increased 12-fold (McCarthy, Barker-Gibb et al. 2002). 
This increase in expression of TrkA is also observed in medial septum neurons, and for 
levels of BDNF in the hippocampus, but not NGF (Gibbs 1998). Mutated BDNF can lead 
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to increased anxiety behavior, impaired memory, and increased expression of BDNF and 
its receptor TrkB in the hippocampal formation, and also alters the fluctuation of protein 
expression observed across the estrous cycle (Spencer, Waters et al. 2010). Additionally, 
in the hippocampus of mice, TrkB is phosphorylated during high-estradiol states(i.e. 
proestrus in females) than lower estradiol states(estrus and diestrus in females and males) 
(Spencer-Segal, Waters et al. 2011), an increase that also is accompanied by a period of 
greater hippocampal excitability (Scharfman, Mercurio et al. 2003). These studies 
highlight 1) that different stages of the estrous cycle can lead to differential changes in 
gene expression of neurotrophins 2) that different stages of the estrous cycle can alter 
BDNF levels, which leads to changes both to the activity of individual neurons and 
behavior of the animal. Despite these documented interactions, the exact contributions of 
hormone levels and stages of the estrous cycle to our data are unclear. 
 Another consideration is activity levels of the animals before sacrifice. 
Specifically, changes in the activity level could alter the induction of immediate early 
genes, such as c-Fos. c-Fos has been used as a marker for many cellular processes, 
including activity (Jasmin, Gogas et al. 1994), hormonal activation (Li, Hand et al. 1997), 
as well as neurotrophin binding (Boyce, Park et al. 2012). Spinal cord injury can also 
induce expression of immediate early genes. After a spinal cord crush injury, levels of 
immediate early genes, cytokines, and neurotrophins show a sequential expression pattern 
that differs with time. c-fos and c-Jun reach peak levels an hour after injury, persisting for 
up to 6 hours; followed by cytokines TNFa and IL6  which reach their peak expression 
levels around 3 hours, persisting up to 12 hours; and then the neurotrophins NT3 and 
BDNF begin to be upregulated at 12 hours (Hayashi, Ueyama et al. 2000). Relating this 
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to activity period after sacrifice, animals that were sacrificed earlier in the day (close to 
the night, their period of highest activity), would be more likely to have increased c-Fos 
(for example) levels relative to those sacrificed at later times in the day. From the study 
above it appears that this induction of immediate early genes does not begin to affect 
neurotrophin levels until around 9 hours after these genes reach their peak, thus 
neurotrophin levels would likely be higher later in the day, assuming a direct link 
between activity, immediate early gene expression, and neurotrophin expression. The fact 
that the animals were sacrificed in a sequential manner throughout the day (from 
approximately 10am to 5 pm) and that we still found consistently elevated expression 
levels in some groups, it seems unlikely that these factors played a significant role in 
influencing the data. Nevertheless, it certainly would have been useful to have some 
measure of activity, and similar future studies should attempt to address these concerns. 
  Though the manipulation of expression of the neurotrophins and/or Trk receptors 
might seem beneficial when viewed alone for purposes of cell survival, or alteration of 
excitability of a certain population of cells, these studies also highlight an idea that has 
not been explored thus far with regard to neurotrophins. Though neurotrophins/Trk 
receptors have been largely been investigated under that assumption that they have 
discrete functions on discrete populations of cells, it is also possible that manipulation of 
any one component of their signaling or expression system could alter the others in a way 
that could be maladaptive. Take for instance the effects of NT3, which has established 
functions as potentiating the excitability of proprioceptive neurons in both the DRG and 
spinal cord (Klein, Silos-Santiago et al. 1994). If one were to attempt to overexpress NT3 
as a means of enhancing the excitability of this system, it could inadvertently lead to 
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overexpression of NGF as well (Mendell, Albers et al. 1999), which has documented 
effects of leading to hyperexcitability of nociceptive neurons (though NT3 can have anti-
nociceptive properties (Shu XQ 1999) as well, thus may serve to mitigate this effect to an 
extent).  Conversely, reducing expression of NGF to ameliorate pain could lead to 
unwanted effects on proprioceptive circuits. Accordingly, investigations that involve 
neurotrophins/Trk receptors should take into account the effect that manipulation of one 
component could have on all others, both through expression analysis and functionally. 
Furthermore, as side effects are a common reason for cessation of many therapies, this is 
also important with regard to clinical studies that involve neurotrophins.  
 Taken together, these findings point to what appears to be a set of overlapping 
interactions that ultimately produce a coordinated transcriptional network.  After a 
contusive injury to the thoracic spinal cord, a degree of descending input to the lumbar 
cord is lost based on the exact nature of the injury. These inputs are heterogeneous in 
nature in terms of neurotransmitter content of the spared tracts, and the location in the 
lumbar cord onto which the tracts synapse. Despite this heterogeneity, the resulting effect 
of this loss of descending input is loss of function of the output of lumbar circuits (i.e. 
lower motoneurons), and loss of molecular interactions between synapses of the 
descending tracts and the axons/dendrites/synapses present in the lumbar cord. Likely at 
play in the acute setting of the injury is the release of inflammatory/stress molecules from 
the spared descending synapses that is due to their interaction with the still dynamic 
molecular setting of the injury site. After time has passed and the cord has “adjusted” to 
the different environment and dynamic events have ceased, it appears based on our work 
that an external factor begins to regulate the expression of the neurotrophins and their 
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cognate Trk receptors in a “coordinated” manner. Based on our results, CCL2 seems to 
be a potential contributor to such a process, as it is dramatically upregulated at time 
points when we see this phenomenon of coordinated expression (Fig 20) and has been 
previously shown to effect large, medium, and small diameter cells of the DRG, which 
represent all different subclasses of neurons on which Trk receptors are present (White, 
Sun et al. 2005). 
 Though this is one mechanism that may be present, a separate mechanism, 
perhaps one that is activity dependent also appears to regulate the levels of the 
neurotrophins and the Trk receptors. Such an activity dependent mechanism could be 
based on a level of activity that is determined by injury severity, i.e. motor neuron pools 
with greater levels of spared descending input lead to more motor output which leads to a 
greater level of basal activity in the DRG. Summarily, both activity dependent and 
independent mechanisms could be at play simultaneously to achieve a spectrum of 
expression levels. Alternatively, differing levels of motoneuron output could lead to 
release of a common factor/molecule in the periphery that is motoneuron activity 
dependent but not dependent on levels of afferent activity.  Whether this process is 
beneficial or maladaptive to the entire system depends on a variety of factors, including 
(but not limited to); the relative contributions of each trophic factor to the overall activity 
of the system, how much the expression level of one factor influences the other, and the 
severity of the injury and what types of information are relays to more rostral levels of 
the nervous system. These findings have an impact not only as novel discoveries, but 
could also have implications for the utility of different therapeutic approaches used to 
help patients with spinal cord injury. Ultimately, only further investigation into the 
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precise mechanisms that govern such processes will determine their impact on future 


























Figure 1: In ASIA A/B patients (complete motor loss) and ASIA C/D patients 
(incomplete motor loss) with body weight supported treadmill training (BWST), levels of 
activation of motor neuron pools show drastic spatiotemporal changes when compared 












Figure 2: Treadmill training improves both maximum speed of stepping and the number 











Figure 3: Contusive spinal cord injury results in decreased expression of BDNF, but does 
not change NT3 expression. Exercise after contusive spinal cord injury results in levels of 
BDNF and NT3 expression that are elevated relative to what is observed after contusive 




























Figure 4: Neurotrophic factor treatment(NTF) after thoracic transection of the cat spinal 
cord produces the same effect as treadmill training(trained) after transection. 
Combination of training and neurotrophic factor treatment results in similar kinematic 







Figure 5: BDNF decreases the amplitude of the EPSP in motoneurons after afferent 
stimulation. NT3 increases the amplitude of the EPSP in motoneurons after afferent 













Figure 6.  Injuries were characterized 
using BBB scores to assess hindlimb 
locomotor function and white matter 
sparing (WMS) at epicenter using EC 
stain. (A)  BBB scores of groups that 
received 12.5 g-cm (blue) or 25 g-cm 
(green) NYU injuries.  Starting at week 
5, a significant difference was observed 
between the two injury severities.  Both 
groups were significantly different 
(p<0.05) from controls (not shown) at all 
time points.  (B)  White matter sparing at 
epicenter (x-axis) plotted versus BBB 
score.  Black dots represent 6 week 
values.  Green dots represent 12 week, 25 
g-cm injured animals.  Blue x represent 
the two animals from the 12 week, 12.5 
g-cm group with the lowest BBB scores within the group.  Blue dots represent the four 
animals from the 12 week, 12.5 g-cm group with the highest BBB scores within the 
group.   (C)  Image taken from a 12.5 g-cm contused animal showing a laterally-
symmetrical injury pattern at the epicenter.  Note the difference from (D), which was 
taken from an animal that also received a 12.5 g-cm spinal cord contusion but which 








mRNA expression of Trk receptors is altered in L4/5 DRG at 6 and 12 weeks after 
receiving either 12.5 g-cm(blue) or 25 g-cm(green) NYU contusion injury to spinal cord 
at vertebral level T9. Fold change (F.C.) is reported as change of 12 week relative to 6 
week time points in all figures.  Black bar on TrkA reports fold-change (f.c.) of 25 g-cm 
at 12 weeks relative to 12.5 g-cm at 12 weeks. X axis denotes weeks post injury.  White 
lines in box-plots indicate group mean.  Dotted gray lines indicate expression level of 
controls (normalized to 1), with ± s.e.m. indicated by the vertical arrows at right end of 














mRNA expression of Neurotrophins is altered in L4/5 DRG at 6 and 12 weeks after 
receiving either 12.5 g-cm (blue) or 25 g-cm (green) NYU contusion injury to spinal cord 
at vertebral level T9. Fold-change (f.c.) is reported as change of 12 week relative to 6 
week time points in all figures. X axis denotes weeks post injury.  White lines in box-
plots indicate group mean.  Dotted gray lines indicate expression level of controls 
(normalized to 1), with ± s.e.m. indicated by the vertical arrows at right end of the control 
















mRNA expression of Trk receptors is altered in L4/5 spinal cord at 6 and 12 weeks after 
receiving either 12.5 g-cm (blue) or 25 g-cm (green) NYU contusion injury to spinal cord 
at vertebral level T9. Fold-change (f.c.) is reported as change of 12 week relative to 6 
week time points in all figures.  X axis denotes weeks post injury. White lines in box-
plots indicate group mean.  Dotted gray lines indicate expression level of controls 
(normalized to 1), with ± s.e.m. indicated by the vertical arrows at right end of the control 







A) Scatterplots of Neurotrophin mRNA expression in L4/5 SC at 6 and 12 weeks after 
receiving either 12.5 g-cm (blue) or 25 g-cm (green) NYU contusion injury to spinal cord 
at vertebral level T9, relative to the unified control group as was done for the other data.  
x's represent mRNA expression of age-matched naive animals.  Open circles represent 
expression of age-matched laminectomy control animals. *p<0.05, **p<0.01 
B) mRNA expression of Neurotrophins in L4/5 SC at 6 and 12 weeks after receiving 
either 12.5 g-cm (blue) or 25 g-cm (green) NYU contusion injury to spinal cord at 
vertebral level T9, relative to their respective age matched control groups. X axis 
denotes weeks post injury.  White lines in box-plots indicate group mean.  Dotted gray 
lines indicate expression level of controls (normalized to 1), with ± s.e.m. indicated by 



























































Figure 13: NT3 expression is elevated at 9 months post birth relative to both 3 and 6 
















Figure 14: Correlated expression of neurotrophins in DRG emerges at chronic time 
points.  Blue dots represent animals with 12.5 g-cm injuries.  Green dots represent 
animals with 25 g-cm injuries. Values represent fold-change of the individual animals 





























Figure 15: Correlated expression of Trk receptors in DRG emerges at chronic time points.  
Values represent fold-change of the individual animals versus mean of control group.  
Blue dots represent animals with 12.5 g-cm injuries.  Green dots represent animals with 




























Figure 16: No change was observed between any injury severity or time point in the DRG 















































Figure 17: No change was observed between any injury severity or time point in the DRG 












Figure 18: GP130 is decreased in 25 g-cm injury severity group at both time points 





































Figure 19: CNTF expression increases at 12 weeks in both injury severities. Control 
group at 12 weeks time point also increases(top). Relative to time matched control, 
CNTF expression is increased at 6 weeks in the 25 g-cm injury severity, no change 
relative to 12 week time matched control. Black bar represents mRNA expression of 
control group. Blue bar represents mRNA expression of 12.5g-cm injury severity group. 

































Figure 20: CCL2 expression increases at 12 weeks post contusive spinal cord injury. 
Black bars represent mRNA expression of control group. Blue bars represent mRNA 
expression of 12.5 g-cm injury severity group. Green bars represent mRNA expression of 








Figure 21.  Control expression values of all groups assessed for mRNA levels of 
neurotrophins and Trk receptors in the DRG. An initial statistical analysis(t-test) was 
performed to determine if an age dependent change existed between our 6 and 12 week 
control groups. After performing this analysis we determined that no age related changes 
existed for our expression values in the DRG. Thus, all control relative expression values 
were combined, averaged, and then normalized to the combined average of all control 
values for each molecule labeled on the x-axis (denoted as f.c. all control on y-axis). Red 













Figure 22. Control expression values of all groups assessed for mRNA levels of 
neurotrophins and Trk receptors in the spinal cord. An initial statistical analysis(t-test) 
was performed to determine if an age dependent change existed between our 6 and 12 
week control groups. After performing this analysis we determined that no age related 
changes existed for our Trk receptor expression values in the spinal cord, but an apparent 
age related change in controls did exist for the neurotrophins in the spinal cord. All 
control relative expression values were combined, averaged, and then normalized to the 
combined average of all control values for each molecule labeled on the x-axis (denoted 
as f.c. all control on y-axis) Due to the difference observed for neurotrophin expression 
values in controls, further analysis was also performed relative to expression values of 
time matched controls at 6 and 12 week time points (Figure 10). Red X: 12 week control 
expression values. Black dot: 6 week control expression values. *p<0.05 
83 
 

















Table 2. Correlations between expression of mRNA for trk receptors in spinal cord.  
 
 
r‐value p‐value r‐value p‐value r‐value p‐value
TrkA vs TrkB 0.47 0.2 0.25 0.46 0.19 0.56
TrkA vs TrkC 0.42 0.26 0.21 0.53 0.4 0.19















































Table 3.  Correlations between expression of mRNA for neurotrophins, Trk receptors, 
and cognate pairs. 
 
r‐value p‐value r‐value p‐value r‐value p‐value
NGF vs BDNF 0.20 0.61 0.15 0.69 0.84 0.001
NGF vs NT3 0.72 0.03 0.87 0.003 0.92 0.00006
BDNF vs NT3 0.10 0.80 0.33 0.38 0.88 0.0004
TrkA vs TrkB 0.04 0.90 0.005 0.989 0.89 0.0007
TrkA vs TrkC 0.56 0.11 0.61 0.08 0.79 0.006
TrkB vs TrkC 0.40 0.28 0.38 0.31 0.78 0.004
NGF vs TrkA 0.65 0.06 0.55 0.13 0.88 0.0004
BDNF vs TrkB 0.45 0.22 0.69 0.04 0.77 0.005





















with a “:” have 
binding sites 
situated such that 








by a “,”share 
binding sites or 
have binding sites 
situated near each 
other such that 
the factors act in 
competition with 
each other. 
TF Binding-site name HGNC symbol TrkA NGF TrkB BDNF TrkC NTF3
AhR AHR x x x
AhR:Arnt x
AP-1 FOS; FOSB; JUN; JUND x x
AP-2 TFAP2A x x x x
AR AR x x
Arnt ARNT x
ATF ATF x x
ATF2 ATF2 x x x x
ATF2:cJun x
Brn-2 POU3F2 x
C/EBP CEBPA,B,D,E,G,Z x x
CAR NR1I3 x
c-Ets-2 ETS2 x
c-Jun JUN x x
c-Myc:Max x
COUP-TF1 NR2F1 x x x
CREB CREB1 x x x x x
CREB,ATF x
CREM CREM x x
DEC BHLHE40 x x x
E2A TCF3 x
Ebox TCF3; MYOD1; MYOG x
ER-alpha ESR1 x x
Ets ETS1,2; ETV1,2,3,4,5,6,7 x x x
Foxj1 FOXJ1 x
FOXO1 FOXO1 x
GATA-3 GATA3 x x
GR NR3C1 x x x
HES1 HES1 x x
HOXA5 HOXA5 x
HOXB8 HOXB8 x
KROX EGR1,2; ZNF22; ZBTB7B x
MAF MAF x x x x
MAFB MAFB x x x x x
Max MAX x x x
MEF-2 MEF2A x
MEF-2C MEF2C x
Myc MYC x x
Neuro D NEUROD1 x x x x x
NFAT1 NFATC2 x x x x




NURR1 NR4A2 x x x
Oct-1 POU2F1 x x
Octamer POU family of proteins x x
Oct-x STAT1 x
p53 TP53 x
Pax-3 PAX3 x x x x x
Pax-6 PAX6 x
Pax-8 PAX8 x x x






RXR-alpha RXRA x x
SF1 SF1 x
SMAD MADH family of proteins x x
Smad3 SMAD3 x x
Sox1 SOX1 x x
Sox2 SOX2 x
Sp1 SP1 x x x x
SRF SRF x
Sry SRY x x x
STAT SOAT1 x x x
STAT1 STAT1 x
STAT3 STAT3 x x
Tax CNTN2 x
Tax/CREB x x
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